PALANTIR TECHNOLOGIES INC., 10-K filed on 2/20/2024
Annual Report
v3.24.0.1
Cover Page - USD ($)
$ in Billions
 12 Months Ended
Dec. 31, 2023
Feb. 13, 2024
Jun. 30, 2023
Document Information [Line Items]      
Document Type 10-K    
Document Quarterly Report true    
Current Fiscal Year End Date --12-31    
Document Period End Date Dec. 31, 2023    
Document Transition Report false    
Entity File Number 001-39540    
Entity Registrant Name Palantir Technologies Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 68-0551851    
Entity Address, Address Line One 1200 17th Street, Floor 15    
Entity Address, City or Town Denver    
Entity Address, State or Province CO    
Entity Address, Postal Zip Code 80202    
City Area Code (720)    
Local Phone Number 358-3679    
Title of 12(b) Security Class A Common Stock, par value $0.001 per share    
Trading Symbol PLTR    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 29.3
Documents Incorporated by Reference
Documents Incorporated by Reference
Portions of the registrant’s Definitive Proxy Statement relating to the Annual Meeting of Stockholders to be held in 2024 are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended December 31, 2023.
    
Entity Central Index Key 0001321655    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag false    
Class A Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   2,110,901,985  
Class B Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   100,826,007  
Class F Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   1,005,000  
v3.24.0.1
Audit Information
 12 Months Ended
Dec. 31, 2023
Audit Information [Abstract]  
Auditor Firm ID 42
Auditor Name Ernst & Young LLP
Auditor Location San Jose, California
v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 831,047 $ 2,598,540
Marketable securities 2,843,132 35,135
Accounts receivable, net 364,784 258,346
Prepaid expenses and other current assets 99,655 149,556
Total current assets 4,138,618 3,041,577
Property and equipment, net 47,758 69,170
Operating lease right-of-use assets 182,863 200,240
Other assets 153,186 150,252
Total assets 4,522,425 3,461,239
Current liabilities:    
Accounts payable 12,122 44,788
Accrued liabilities 222,991 172,715
Deferred revenue 246,901 183,350
Customer deposits 209,828 141,989
Operating lease liabilities 54,176 45,099
Total current liabilities 746,018 587,941
Deferred revenue, noncurrent 28,047 9,965
Customer deposits, noncurrent 1,477 3,936
Operating lease liabilities, noncurrent 175,216 204,305
Other noncurrent liabilities 10,702 12,655
Total liabilities 961,460 818,802
Commitments and Contingencies (Note 8)
Stockholders’ equity:    
Common stock 2,200 2,099
Additional paid-in capital 9,122,173 8,427,998
Accumulated other comprehensive income (loss), net 801 (5,333)
Accumulated deficit (5,649,613) (5,859,438)
Total stockholders’ equity 3,475,561 2,565,326
Noncontrolling interests 85,404 77,111
Total equity 3,560,965 2,642,437
Total liabilities and equity $ 4,522,425 $ 3,461,239
v3.24.0.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Common stock, shares authorized (in shares) 22,701,005,000 22,701,005,000
Common stock, shares issued (in shares) 2,200,128,000 2,099,075,000
Common stock, shares outstanding (in shares) 2,200,128,000 2,099,075,000
Class A Common Stock    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 20,000,000,000 20,000,000,000
Common stock, shares issued (in shares) 2,096,982,000 1,995,414,000
Common stock, shares outstanding (in shares) 2,096,982,000 1,995,414,000
Class B Common Stock    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 2,700,000,000 2,700,000,000
Common stock, shares issued (in shares) 102,141,000 102,656,000
Common stock, shares outstanding (in shares) 102,141,000 102,656,000
Class F Common Stock    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 1,005,000 1,005,000
Common stock, shares issued (in shares) 1,005,000 1,005,000
Common stock, shares outstanding (in shares) 1,005,000 1,005,000
v3.24.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenue $ 2,225,012 $ 1,905,871 $ 1,541,889
Cost of revenue 431,105 408,549 339,404
Gross profit 1,793,907 1,497,322 1,202,485
Operating expenses:      
Sales and marketing 744,992 702,511 614,512
Research and development 404,624 359,679 387,487
General and administrative 524,325 596,333 611,532
Total operating expenses 1,673,941 1,658,523 1,613,531
Income (loss) from operations 119,966 (161,201) (411,046)
Interest income 132,572 20,309 1,607
Interest expense (3,470) (4,058) (3,640)
Other income (expense), net (11,977) (216,077) (75,415)
Income (loss) before provision for income taxes 237,091 (361,027) (488,494)
Provision for income taxes 19,716 10,067 31,885
Net income (loss) 217,375 (371,094) (520,379)
Less: Net income attributable to noncontrolling interests 7,550 2,611 0
Net income (loss) attributable to common stockholders $ 209,825 $ (373,705) $ (520,379)
Net earnings (loss) per share attributable to common stockholders, basic (in dollars per share) $ 0.10 $ (0.18) $ (0.27)
Net earnings (loss) per share attributable to common stockholders, diluted (in dollars per share) $ 0.09 $ (0.18) $ (0.27)
Weighted-average shares of common stock outstanding used in computing net earnings (loss) per share attributable to common stockholders, basic (in shares) 2,147,446 2,063,793 1,923,617
Weighted-average shares of common stock outstanding used in computing net earnings (loss) per share attributable to common stockholders, diluted (in shares) 2,297,927 2,063,793 1,923,617
v3.24.0.1
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of Comprehensive Income [Abstract]      
Net income (loss) $ 217,375 $ (371,094) $ (520,379)
Other comprehensive income (loss)      
Foreign currency translation adjustments 2,699 (2,984) 396
Net unrealized gain (loss) on available-for-sale securities 3,435 0 0
Comprehensive income (loss) 223,509 (374,078) (519,983)
Less: Comprehensive income attributable to noncontrolling interests 7,550 2,611 0
Comprehensive income (loss) attributable to common stockholders $ 215,959 $ (376,689) $ (519,983)
v3.24.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss), Net
Accumulated Deficit
Parent
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2020   1,792,140,000          
Beginning balance at Dec. 31, 2020 $ 1,522,550 $ 1,792 $ 6,488,857 $ (2,745) $ (4,965,354)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares)   178,849,000          
Issuance of common stock from the exercise of stock options 507,455 $ 178 507,277        
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)   50,350,000          
Issuance of common stock upon vesting of restricted stock units (“RSUs”) 0 $ 50 (50)        
Issuance of common stock upon vesting of growth units (shares)   1,471,000          
Issuance of common stock upon vesting of growth units 0 $ 1 (1)        
Issuance of common stock upon net exercise of common stock warrants and other (in shares)   4,664,000          
Issuance of common stock upon net exercise of common stock warrants and other 1,712 $ 6 1,706        
Stock-based compensation 779,296   779,296        
Other comprehensive income (loss) 396     396      
Net income (loss) (520,379)       (520,379)    
Ending balance (in shares) at Dec. 31, 2021   2,027,474,000          
Ending balance at Dec. 31, 2021 2,291,030 $ 2,027 7,777,085 (2,349) (5,485,733) $ 2,291,030 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares)   19,660,000          
Issuance of common stock from the exercise of stock options 86,088 $ 20 86,068     86,088  
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)   51,941,000          
Issuance of common stock upon vesting of restricted stock units (“RSUs”) 0 $ 52 (52)        
Stock-based compensation 564,897   564,897     564,897  
Other comprehensive income (loss) (2,984)     (2,984)   (2,984)  
Noncontrolling interests 74,500           74,500
Net income (loss) $ (371,094)       (373,705) (373,705) 2,611
Ending balance (in shares) at Dec. 31, 2022 2,099,075,000 2,099,075,000          
Ending balance at Dec. 31, 2022 $ 2,642,437 $ 2,099 8,427,998 (5,333) (5,859,438) 2,565,326 77,111
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares) 46,079,000 46,079,000          
Issuance of common stock from the exercise of stock options $ 218,238 $ 46 218,192     218,238  
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)   54,974,000          
Issuance of common stock upon vesting of restricted stock units (“RSUs”) 0 $ 55 (55)        
Stock-based compensation 476,038   476,038     476,038  
Other comprehensive income (loss) 6,134     6,134   6,134  
Other, net 743           743
Net income (loss) $ 217,375       209,825 209,825 7,550
Ending balance (in shares) at Dec. 31, 2023 2,200,128,000 2,200,128,000          
Ending balance at Dec. 31, 2023 $ 3,560,965 $ 2,200 $ 9,122,173 $ 801 $ (5,649,613) $ 3,475,561 $ 85,404
v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating activities      
Net income (loss) $ 217,375 $ (371,094) $ (520,379)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 33,354 22,522 14,897
Stock-based compensation 475,903 564,798 778,215
Deferred income taxes (4,806) (174) 43,316
Noncash operating lease expense 47,019 40,309 33,821
Unrealized and realized (gain) loss from marketable securities, net 13,160 272,108 73,311
Noncash consideration (46,609) (15,537) 0
Gain from step acquisition 0 (44,306) 0
Other operating activities (29,449) 16,328 2,767
Changes in operating assets and liabilities, net of effect of acquisitions:      
Accounts receivable, net (106,159) (72,819) (35,237)
Prepaid expenses and other current assets (6,197) (24,811) (10,974)
Other assets 3,242 6,033 (3,345)
Accounts payable (31,832) (29,859) 57,767
Accrued liabilities 52,895 5,527 15,245
Deferred revenue, current and noncurrent 79,512 (61,154) 24,732
Customer deposits, current and noncurrent 64,347 (49,471) (104,944)
Operating lease liabilities, current and noncurrent (49,630) (34,590) (32,156)
Other noncurrent liabilities 58 (73) (3,185)
Net cash provided by operating activities 712,183 223,737 333,851
Investing activities      
Purchases of property and equipment (15,114) (40,027) (12,627)
Purchases of marketable securities (5,636,406) (124,500) (308,315)
Proceeds from sales and redemption of marketable securities 2,889,268 52,319 851
Business combinations, net of cash acquired 0 66,708 0
Purchases of alternative investments 0 0 (50,941)
Proceeds from sales of alternative investments 51,072 0 0
Purchases of privately-held securities 0 0 (23,009)
Other investing activities 0 73 (3,871)
Net cash used in investing activities (2,711,180) (45,427) (397,912)
Financing activities      
Principal payments on borrowings 0 0 (200,000)
Proceeds from the exercise of common stock options 218,238 86,089 507,455
Other financing activities 601 (93) (708)
Net cash provided by financing activities 218,839 85,996 306,747
Effect of foreign exchange on cash, cash equivalents, and restricted cash 2,930 (3,885) (3,918)
Net increase (decrease) in cash, cash equivalents, and restricted cash (1,777,228) 260,421 238,768
Cash, cash equivalents, and restricted cash - beginning of period 2,627,335 2,366,914 2,128,146
Cash, cash equivalents, and restricted cash - end of period 850,107 2,627,335 2,366,914
Supplemental disclosures of cash flow information      
Cash paid for income taxes $ 13,515 $ 2,904 $ 4,131
v3.24.0.1
Organization
 12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
 Organization Organization
Palantir Technologies Inc. (including its subsidiaries, “Palantir” or the “Company”) was incorporated in Delaware on May 6, 2003. The Company builds and deploys software platforms that serve as the central operating systems for its customers.
v3.24.0.1
Significant Accounting Policies
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies Significant Accounting Policies
Basis of Presentation and Consolidation
The accompanying consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding annual financial reporting. The accompanying consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over, but does not control, the investee are accounted for using the equity method of accounting. Certain prior year balances have been reclassified to conform to the current year presentation. Such reclassifications did not affect total revenues, income (loss) from operations, net income (loss), or cash flows. The Company’s fiscal year ends on December 31.
Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods.
Significant estimates and assumptions made in the accompanying consolidated financial statements include, but are not limited to, the identification of performance obligations in customer contracts, the valuation of deferred tax assets and uncertain tax positions, and the collectability of contract consideration, including accounts receivable. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations.
Segments
The Company has two operating segments, commercial and government, which were determined based on the manner in which the chief operating decision maker (“CODM”), who is the Chief Executive Officer, manages the operations of the Company for purposes of allocating resources and evaluating performance. Various factors, including the Company’s organizational and management reporting structure and customer type, were considered in determining these operating segments.
The Company’s operating segments are described below:
•Commercial: This segment primarily serves customers working in non-government industries.
•Government: This segment primarily serves customers that are United States (“U.S.”) government and non-U.S. government agencies.
Cash, Cash Equivalents, and Restricted Cash
The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds and available-for-sale debt securities.
Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the amounts shown in the consolidated statements of cash flows (in thousands):
As of December 31,
202320222021
Cash and cash equivalents$831,047 $2,598,540 $2,290,674 
Restricted cash included in prepaid expenses and other current assets370 16,244 36,628 
Restricted cash included in other assets18,690 12,551 39,612 
Total cash, cash equivalents, and restricted cash$850,107 $2,627,335 $2,366,914 
Accounts Receivable and Allowance for Credit Losses
Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. The Company generally grants non-collateralized credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are written-off and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the Company’s assessment as of December 31, 2023 and 2022, the Company recorded an allowance for credit losses of $10.5 million and $10.1 million, respectively.
Debt Securities
Debt securities are primarily comprised of U.S. treasury securities. The debt securities are classified as available-for-sale at the time of purchase and are reevaluated as of each balance sheet date. The Company considers the majority of its available-for-sale debt securities as available for use in current operations and may sell these securities at any time, and therefore classifies these securities as current assets in its consolidated balance sheets. Debt securities included in marketable securities on the consolidated balance sheets consist of U.S. treasury securities with original maturities of greater than three months at the time of purchase, and the remaining U.S. treasury securities are included in cash and cash equivalents. Interest income on debt securities is included in other income (expense), net on the consolidated statements of operations.
The majority of the Company’s available-for-sale securities are recorded at fair value each reporting period using quoted prices of similar instruments and are classified within Level 2 of the fair value hierarchy. The Company evaluates investments with unrealized loss positions for other than temporary impairment by assessing if they are related to deterioration in credit risk and whether it expects to recover the entire amortized cost basis of the security, the Company’s intent to sell, and whether it is more likely than not that the Company will be required to sell the securities before the recovery of their cost basis. Credit-related impairment losses, not to exceed the amount that fair value is less than the amortized cost basis, are recognized in other income (expense), net in the consolidated statements of operations. Unrealized gains and non-credit related losses are reported as a separate component of accumulated other comprehensive loss, net in the consolidated balance sheets until realized. Realized gains and losses and declines in value judged to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net in the consolidated statements of operations.
Concentrations of Credit Risk
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, accounts receivable, marketable securities, and privately-held equity securities. Cash equivalents primarily consist of money market funds and U.S. treasury securities with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts.
The Company is exposed to concentrations of credit risk with respect to accounts receivable presented in the consolidated balance sheets. The Company’s accounts receivable balances as of December 31, 2023 and 2022 were $364.8 million and $258.3 million, respectively. Customer I represented 15% of total accounts receivable as of December 31, 2023, and no other customer represented more than 10% of total accounts receivable as of December 31, 2023. No customer represented more than 10% of total accounts receivable as of December 31, 2022. 
For the years ended December 31, 2023, 2022, and 2021, no customer represented 10% or more of total revenue.
Alternative Investments
Alternative investments include gold bars and are recorded in prepaid expenses and other current assets on the consolidated balance sheets. The investments are initially recorded at cost and subsequently remeasured at the lower of cost or market each reporting period. Market value is determined by using quoted market prices of identical or similar assets from active markets. Unrealized losses are recorded in other income (expense), net in the consolidated statements of operations. Realized gains and losses are recorded in other income (expense), net upon realization.
Property and Equipment, Net
Property and equipment, net are stated at cost less accumulated depreciation and amortization. Depreciation is recognized using the straight-line method over the estimated useful lives of the respective assets, which are generally three years. Leasehold improvements are capitalized and amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful life, which is generally five years. Maintenance and repairs that do not improve or extend the useful lives of the assets are expensed when incurred. Upon sale or retirement of assets, the cost and related accumulated depreciation and amortization are derecognized from the consolidated balance sheets and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized.
Privately-held Equity Securities
Equity securities in privately-held companies without readily determinable fair values are recorded using the measurement alternative. Such investments are carried at cost, less any impairments, and are adjusted for subsequent observable price changes in orderly transactions for identical or similar investments of the same issuer. Changes in the basis of the equity securities are recognized in other income (expense), net in the consolidated statements of operations.
Business Combinations
Business combinations are accounted for using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations, and are included in our consolidated financial statements from their respective acquisition dates. Assets acquired and liabilities assumed, if any, are measured at fair value on the acquisition date using the appropriate valuation method. Goodwill generated from acquisitions is recognized if the fair value of the purchase consideration transferred, or the fair value of the acquirer’s interest in the acquiree if no consideration is transferred, and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. In determining the fair value of identifiable assets, we use various valuation techniques which require us to make estimates and assumptions surrounding projected revenues and costs, future growth, and discount rates.
Goodwill
Goodwill represents the excess of the fair value of the purchase consideration transferred, or the fair value of the acquirer’s interest in the acquiree if no consideration is transferred, and any noncontrolling interests over the net fair value of the identifiable assets acquired and the liabilities assumed in business combinations. Goodwill is not amortized but is subject to an annual impairment test. We perform our annual goodwill impairment assessment on the first day of the fourth quarter. Tests are performed more frequently if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Goodwill is recorded in other assets in the consolidated balance sheet.
Other Intangible Assets
Other intangible assets include finite-lived intangible assets, which mainly consist of customer relationships, reacquired rights, and backlog. These assets are amortized over their estimated useful lives and are tested for impairment using a similar methodology to our property and equipment, as described below. Other intangible assets are recorded in other assets in the consolidated balance sheets.
Impairment of Long-Lived Assets
Long-lived assets are reviewed for impairment annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparing the carrying amount of an asset to the future undiscounted cash flows that the asset is expected to generate. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Impairments of long-lived assets during the years ended December 31, 2023, 2022, and 2021 were not material.
Leases
The Company determines if an arrangement is a lease at inception. An arrangement is or contains a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If a lease is identified, classification is determined at lease commencement. Operating lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The Company’s leases do not provide an implicit interest rate and therefore the Company estimates its incremental borrowing rate to discount lease payments. The incremental borrowing rate reflects the interest rate that the Company would have to pay to borrow on a collateralized basis an amount equal to the lease payments in a similar economic environment over a similar term. Operating lease right-of-use (“ROU”) assets are based on the corresponding lease liability adjusted for any lease payments made at or before commencement, initial direct costs, and lease incentives. Renewals or early terminations are not accounted for unless the Company is reasonably certain to exercise these options. Operating lease expense is recognized and the ROU asset is amortized on a straight-line basis over the lease term.
The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. For short-term leases, defined as leases with a term of twelve months or less, the Company elected the practical expedient to not recognize an associated lease liability and ROU asset. Lease payments for short-term leases are expensed on a straight-line basis over the lease term.
Operating leases are included in operating lease right-of-use assets, operating lease liabilities, and operating lease liabilities, non-current on the Company’s consolidated balance sheets. Finance leases are not material.
Fair Value Measurement
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for that asset or liability in an orderly transaction between market participants on the measurement date.
The Company measures fair value based on a three-level hierarchy of inputs, maximizing the use of observable inputs, where available, and minimizing the use of unobservable inputs when measuring fair value. A financial instrument’s level within the three-level hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three-level hierarchy of inputs is as follows:
Level 1: Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;
Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on the Company’s own assumptions about current market conditions and require significant management judgment or estimation.
Financial instruments consist of money market funds and certificates of deposit included in cash equivalents and restricted cash, accounts receivable, marketable securities, other assets accounted for at fair value, accounts payable, and accrued liabilities. Money market funds, certificates of deposit, and marketable securities are stated at fair value on a recurring basis. Accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date.
Revenue Recognition
The Company generates revenue from the sale of subscriptions to access its software platforms in the Company’s hosted environment, along with ongoing operations and maintenance (“O&M”) services (“Palantir Cloud”); software licenses, primarily term licenses in the customers’ environments, with ongoing O&M services (“On-Premises Software”); and professional services.
In accordance with ASC 606, Revenue from Contracts with Customers, the Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company applies the following five-step revenue recognition model in accounting for its revenue arrangements:
•Identification of the contract(s) with the customer, including whether collectability of the consideration is probable by considering the customers’ ability and intention to pay;
•Identification of the performance obligations in the contract;
•Determination of the transaction price;
•Allocation of the transaction price to the performance obligations in the contract; and
•Recognition of revenue when, or as, the Company satisfies a performance obligation.
Additionally, the pricing of the Company’s contracts is generally fixed; however, it is possible for contracts to include variable consideration, which can be based on subjective or objective criteria. The Company includes the estimated amount of variable consideration that it expects to receive to the extent it is probable that a significant revenue reversal will not occur.
Each of the Company’s significant performance obligations and the Company’s application of ASC 606 to its revenue arrangements is discussed in further detail below.
Palantir Cloud
The Company’s Palantir Cloud subscriptions grant customers the right to access the software functionality in a hosted environment controlled by Palantir and are sold together with stand-ready O&M services, as further described below. The Company agrees to provide continuous access to its hosted software platforms throughout the contract term. Revenue associated with Palantir Cloud subscriptions is generally recognized over the contract term on a ratable basis, which is consistent with the transfer of control of the Palantir Cloud subscription to the customer.
On-Premises Software
Sales of the Company’s software licenses, primarily term licenses, grant customers the right to use functional intellectual property, either on their internal hardware infrastructure or on their own cloud instance, over the contractual term and are also sold together with stand-ready O&M services. The O&M services include critical updates, support, and maintenance services required to operate the software and, as such, are necessary for the software to maintain its intended utility over the contractual term. Because of this requirement, the Company has concluded that the software licenses and O&M services, which together the Company refers to as On-Premises Software, are highly interdependent and interrelated and represent a single distinct performance obligation within the context of the contract. Revenue is generally recognized over the contract term on a ratable basis.
Professional Services
The Company’s professional services support the customers’ use of the software platforms and include, as needed, on-demand user support, user-interface configuration, training, and ongoing ontology and data modeling support. Professional services contracts typically include the provision of on-demand professional services for the duration of the contractual term. These services are typically coterminous with a Palantir Cloud subscription or the On-Premises Software. Professional services are on-demand, whereby the Company performs services throughout the contract period; therefore, the revenue is recognized over the contractual term.
Contract Liabilities
The timing of customer billings and payments relative to the start of the service period varies from contract to contract; however, the Company bills many of its customers in advance of the provision of services under its contracts, resulting in contract liabilities consisting of either deferred revenue or customer deposits (“contract liabilities”). Deferred revenue represents billings under noncancelable contracts before the related product or service is transferred to the customer. Customer deposits consist of amounts billed and/or paid in advance of the start of the contractual term or for anticipated revenue generating activities for the portion of a contract term that is subject to cancellation by its customers. Many of the Company’s arrangements include terms that allow the customer to terminate the contract for convenience and receive a pro-rata refund of the amount of the customer deposit for the period of time remaining in the contract term after the applicable termination notice period expires. In these arrangements, the Company concluded there are no enforceable rights and obligations after such notice period and therefore the consideration received or due from the customer that is subject to termination for convenience is recorded as customer deposits.
The payment terms and conditions vary by contract; however, the Company’s terms generally require payment within 30 to 60 days from the invoice date. In instances where the timing of revenue recognition differs from the timing of payment, the Company elected to apply the practical expedient in accordance with ASC 606 to not adjust contract consideration for the
effects of a significant financing component as the Company expects, at contract inception, that the period between when promised goods and services are transferred to the customer and when the customer pays for those goods and services will be one year or less. As such, the Company determined its contracts do not generally contain a significant financing component.
Areas of Judgment and Estimation
The Company’s contracts with customers can include multiple promises to transfer goods or services to the customer. Determining whether promises are distinct performance obligations that should be accounted for separately – or not distinct within the context of the contract and, thus, accounted for together – requires significant judgment. The Company concluded that the promise to provide a software license is highly interdependent and interrelated with the promise to provide O&M services and such promises are not distinct within the context of its contracts and are accounted for as a single performance obligation as the Company’s On-Premises Software.
Significant estimates and assumptions are used in the identification of performance obligations in customer contracts and collectability of contract consideration, including accounts receivable. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect our financial position and results of operations.
Costs to Obtain and Fulfill Contracts
Incremental costs of obtaining a contract include only those costs that are directly related to the acquisition of contracts, including sales commissions, and that would not have been incurred if the contract had not been obtained. The Company recognizes a contract cost asset for the incremental costs of obtaining a contract with a customer if it is expected that the economic benefit and amortization period will be longer than one year. Costs to obtain contracts were not material in the periods presented.
The Company recognizes an asset for the costs to fulfill a contract with a customer if the costs are specifically identifiable, generate or enhance resources used to satisfy future performance obligations, and are expected to be recovered. Costs to fulfill contracts were not material in the periods presented.
Software Development Costs
The Company evaluates capitalization of certain software development costs subsequent to the establishment of technological feasibility. Based on the Company’s product development process and substantial development risks, technological feasibility is generally established for the Company’s products when they are made available for general release. Accordingly, most costs are charged to research and development expense in the period incurred.
Cost of Revenue
Cost of revenue primarily includes salaries, stock-based compensation expense, and benefits for personnel involved in performing O&M and professional services, as well as field service representatives, third-party cloud hosting services, travel costs, allocated overhead, and other direct costs.
Sales and Marketing Costs
Sales and marketing costs primarily include salaries, stock-based compensation expense, commissions, and benefits for the sales force and personnel involved in sales functions, executing on pilots, including bootcamps, and performing other brand building and customer growth activities, as well as third-party cloud hosting services for pilots, marketing and sales event-related costs, travel costs, and allocated overhead. The Company generally charges all such costs to sales and marketing expense in the period incurred. Advertising costs are expensed as incurred and included in sales and marketing expense within the consolidated statements of operations. Advertising expense totaled $21.4 million, $38.6 million, and $26.3 million for the years ended December 31, 2023, 2022, and 2021, respectively.
Research and Development Costs
Research and development costs primarily include salaries, stock-based compensation expense, and benefits for personnel involved in performing the activities to develop and refine the Company’s platforms and products, as well as third-party cloud hosting services and other IT related costs, travel costs, and allocated overhead. Research and development costs are expensed as incurred.
Commitments and Contingencies
Liabilities for loss contingencies arising from claims, disputes, legal proceedings, fines and penalties, and other sources are recorded when it is probable that a liability has been or will be incurred and the amount of the liability can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred. Recoveries of such legal costs from insurance policies are recorded as an offset to legal expenses in the period they are received.
Stock-Based Compensation
The Company accounts for stock-based compensation expense in accordance with the fair value recognition and measurement provisions of GAAP, which require compensation cost for the grant-date fair value of stock-based awards to be recognized over the requisite service period. The Company determines the fair value of stock-based awards granted or modified on the grant date or modification date using appropriate valuation techniques. The Company recognizes forfeitures as they occur.
Service-Based Vesting
The Company grants RSUs and stock option awards that vest based upon the satisfaction of only a service condition. For RSUs, the Company determines the grant-date fair value of the RSUs as the fair value of the Company’s common stock on the grant date. The Company records stock-based compensation expense for stock options and RSUs that vest based upon the satisfaction of only a service condition on a straight-line basis over the requisite service period, which is generally one to four years. For stock option awards, the Company uses the Black-Scholes option pricing model to determine the fair value of the stock options granted. The Black-Scholes option pricing model requires the input of highly subjective assumptions, including the expected term of the option, the expected volatility of the price of the common stock, risk-free interest rates, and the expected dividend yield of the common stock. The assumptions used to determine the fair value of the option awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.
Performance-Based Vesting
The Company also grants awards, including RSUs, that vest upon the satisfaction of both a service condition and a performance condition. The Company determines the grant-date fair value of RSUs with both a service-based vesting condition and a performance-based vesting condition as the fair value of the Company’s common stock on the grant date and records stock-based compensation expense using the accelerated attribution method over the service period. The performance-based vesting condition for the RSUs granted prior to September 30, 2020, the date the Company completed a direct listing of its Class A common stock on the New York Stock Exchange (the “Direct Listing”) was satisfied upon the occurrence of the Company’s Direct Listing. For performance-based RSUs granted after the Direct Listing (“P-RSUs”), the Company recognizes expense from the number of P-RSUs expected to vest, determined based on the level of achievement against certain performance conditions, over the requisite service period when it is probable that the performance condition will be achieved. The probability of achievement is assessed periodically to determine whether the performance metric continues to be probable. When there is a change in the assessment of the probability of achievement, any cumulative effect of the change is recognized in the period of the change and any remaining expense of the related awards is amortized over the remaining service period.
Employee Benefit Plan
The Company sponsors a 401(k) tax-deferred savings plan for all employees who meet certain eligibility requirements. Participants may contribute, on a pretax and post-tax basis, a percentage of their qualifying annual compensation, but not to exceed a maximum contribution amount pursuant to Section 401(k) of the Internal Revenue Code. The Company may make additional matching contributions on behalf of the participants. The Company did not make matching contributions for the years ended December 31, 2023, 2022, and 2021.
Income Taxes
The Company estimates its current tax expense together with assessing temporary differences resulting from differing treatment of items not currently deductible for tax purposes. These differences result in deferred tax assets and liabilities on the Company’s consolidated balance sheets, which are estimated based upon the difference between the financial statement and tax bases of assets and liabilities using the enacted tax rates that will be in effect when these differences reverse. In general, deferred tax assets represent future tax benefits to be received when certain expenses previously recognized in the Company’s consolidated statements of operations become deductible expenses under applicable income tax laws or loss or credit carryforwards are utilized. Accordingly, the realization of the Company’s deferred tax assets is dependent on future taxable income against which these deductions, losses, and credits can be utilized.
The Company evaluates the realizability of its deferred tax assets and recognizes a valuation allowance when it is more likely than not that a future benefit on such deferred tax assets will not be realized. The Company considers all evidence, both positive and negative, in determining any required valuation allowance and evaluates the need for a valuation allowance on a regular basis. The Company performs an assessment of both positive and negative evidence when determining whether it is more likely
than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction by jurisdiction basis. The Company reviews the recognition of deferred tax assets on a regular basis to determine if realization of such assets is more likely than not. A valuation allowance is provided when it is more likely than not that such assets will not be realized. If certain factors change and the Company determines that the deferred tax assets are realizable at a more-likely-than not level, it will adjust the valuation allowance in the period the determination is made. Changes in the valuation allowance, when recorded, would be included in the Company’s consolidated statements of operations. Management’s judgment is required in determining the Company’s valuation allowance recorded against its net deferred tax assets.
The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. The Company recognizes interest and penalties related to uncertain tax positions in its provision for income taxes. The Company is subject to the Global Intangible Low Taxed Income (“GILTI”) tax in the U.S. and has elected to treat taxes on future GILTI inclusions as current period expense if and when incurred.
Net Earnings (Loss) Per Share Attributable to Common Stockholders
The Company computes net earnings (loss) per share attributable to its common stockholders using the two-class method required for participating securities, which determines net earnings (loss) per common share for each class of common stock and participating securities according to dividends declared or accumulated and participation rights in distributed and undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed.
The rights, including the liquidation and dividend rights, of the holders of Class A, Class B, and Class F common stock (collectively, the “common stock”) are identical, except with respect to voting and conversion. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting net earnings (loss) per share will, therefore, be the same for all classes of common stock on an individual or combined basis. As such, the Company has presented the net income (loss) attributed to its common stock on a combined basis.
Noncontrolling Interests
A noncontrolling interest represents the proportionate equity interest in a subsidiary that is not attributable, either directly or indirectly, to the Company and is reported as equity of the Company, separate from the Company’s controlling interest. Revenues, expenses, gains, losses, net income (loss), and other comprehensive income (loss) are reported in the consolidated financial statements at the consolidated amounts, which include the amounts attributable to both the controlling and noncontrolling interest.
Foreign Currency
Generally, the functional currency of the Company’s international subsidiaries is the local currency of the country in which they operate. The Company translates the assets and liabilities of its non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each reporting period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recognized as a cumulative translation adjustment and included in accumulated other comprehensive income (loss).
For transactions that are not denominated in the local functional currency, the Company remeasures monetary assets and liabilities at exchange rates in effect at the end of each reporting period. Transaction gains and losses from the remeasurement are recognized in other income (expense), net within the consolidated statements of operations.
Recent Accounting Pronouncements Not Yet Adopted
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires disclosure of incremental segment information on an annual and interim basis. This standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. The Company is currently evaluating the impacts of the new standard.
In December 2023, the FASB issued ASU 2023-09, Income Taxes – Improvements to Income Tax Disclosures, requiring enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impacts of the new standard.
v3.24.0.1
Contract Liabilities and Remaining Performance Obligations
 12 Months Ended
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]  
Contract Liabilities and Remaining Performance Obligations Contract Liabilities and Remaining Performance Obligations
Contract Liabilities
The Company’s contract liabilities consist of deferred revenue and customer deposits. As of December 31, 2023 and 2022, the Company’s contract liability balances were $486.3 million and $339.2 million, respectively. Revenue of $329.4 million and $384.3 million was recognized during the years ended December 31, 2023 and 2022, respectively, that was included in the contract liabilities balances as of December 31, 2022 and 2021, respectively.
Remaining Performance Obligations
The Company’s arrangements with its customers often have terms that span over multiple years. However, the Company allows many of its customers to terminate contracts for convenience prior to the end of the stated term with less than twelve months’ notice. Revenue allocated to remaining performance obligations represents noncancelable contracted revenue that has not yet been recognized, which includes deferred revenue and, in certain instances, amounts that will be invoiced. The Company has elected the practical expedient allowing the Company to not disclose remaining performance obligations for contracts with original terms of twelve months or less. Cancelable contracted revenue, which includes customer deposits, is not considered a remaining performance obligation.
The Company’s remaining performance obligations were $1.2 billion as of December 31, 2023, of which the Company expects to recognize approximately 52% as revenue over the next 12 months, 37% as revenue over the subsequent 13 to 36 months, and the remainder thereafter.
Disaggregation of Revenue
See Note 13. Segment and Geographic Information for disaggregated revenue by customer segment and geographic region.
v3.24.0.1
Investments and Fair Value Measurements
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Investments and Fair Value Measurements Investments and Fair Value Measurements
The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation (in thousands):
As of December 31, 2023
TotalLevel 1Level 2Level 3
Assets:
Cash and cash equivalents:
Money market funds$576,565 $576,565 $— $— 
U.S. treasury securities10,079 — 10,079 — 
Certificates of deposit938 — 938 — 
Prepaid expenses and other current assets and other assets:
Certificates of deposit4,777 — 4,777 — 
Marketable securities:
U.S. treasury securities2,824,861 — 2,824,861 — 
Publicly-traded equity securities18,271 18,271 — — 
Total$3,435,491 $594,836 $2,840,655 $— 
As of December 31, 2022
TotalLevel 1Level 2Level 3
Assets:
Cash and cash equivalents:
Money market funds$1,149,302 $1,149,302 $— $— 
Certificates of deposit6,791 — 6,791 — 
Prepaid expenses and other current assets and other assets:
Certificates of deposit18,707 — 18,707 — 
Marketable securities:
Publicly-traded equity securities35,135 35,135 — — 
Total$1,209,935 $1,184,437 $25,498 $— 
Certificates of Deposit
The Company’s certificates of deposit are Level 2 instruments. The fair value of such instruments is estimated based on valuations obtained from third-party pricing services that utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable either directly or indirectly. These inputs include interest rate curves, foreign exchange rates, and credit ratings.
Debt Securities
As of December 31, 2023, available-for-sale debt securities consisted of the following (in thousands):
As of December 31, 2023
Amortized CostUnrealized GainsUnrealized LossesFair Value
U.S. treasury securities$2,831,505 $4,520 $(1,085)$2,834,940 
Total debt securities$2,831,505 $4,520 $(1,085)$2,834,940 
Included in cash and cash equivalents$10,078 $1 $— $10,079 
Included in marketable securities$2,821,427 $4,519 $(1,085)$2,824,861 
The Company sold $694.6 million of available-for-sale debt securities during the fiscal year ended December 31, 2023 and immediately reinvested such proceeds into additional available-for-sale debt securities. The realized gains and losses from those sales were immaterial. No credit or non-credit losses related to available-for sale debt securities were recorded as of December 31, 2023. As of December 31, 2023, available-for-sale debt securities of $236.0 million were in an unrealized loss position primarily due to unfavorable changes in interest rates subsequent to initial purchase. None of the available-for-sale debt securities held as of December 31, 2023 were in a continuous unrealized loss position for greater than 12 months. The decline in fair value below amortized cost basis was not considered other than temporary as it is more likely than not that the Company will hold the securities until maturity or a recovery of the cost basis, and no credit-related impairment losses were recorded as of December 31, 2023. All of the Company’s U.S. treasury securities had contractual maturities due within one year as of December 31, 2023.
As of December 31, 2022, the Company held an immaterial amount of debt securities.
Equity Securities
The Company has equity securities consisting of shares held in publicly-traded companies, which are recorded at fair market value each reporting period within marketable securities in the consolidated balance sheets. Additionally, we have accepted, and may continue to accept, securities as noncash consideration. Total equity securities received as noncash consideration was $41.7 million, $6.8 million, and an immaterial amount during the years ended December 31, 2023, 2022, and 2021, respectively. Realized and unrealized gains and losses are recorded in other income (expense), net in the consolidated statements of operations. During the years ended December 31, 2022 and 2021, the Company recorded net unrealized losses of $159.0 million and $72.8 million, respectively, and realized losses of $113.1 million and an immaterial amount during the years ended December 31, 2022 and 2021, respectively, for its publicly-traded equity securities. For the years ended December 31, 2023,
2022, and 2021 net unrealized losses from publicly-traded equity securities held at the end of each period were $4.5 million, $197.3 million, and $72.8 million respectively.
The Company also has equity securities in privately-held companies without readily determinable fair values that are recorded using the measurement alternative. As of December 31, 2023 and December 31, 2022, the total amount of privately-held equity securities included in other assets on the consolidated balance sheets was $32.6 million and $24.4 million, respectively. The Company classifies these fair value measurements as Level 3 within the fair value hierarchy. The Company did not record any material adjustments or impairments for the privately-held equity securities held as of December 31, 2023 and December 31, 2022.
Investments
From 2021 through 2022, the Company approved and entered into certain agreements (“Investment Agreements”) to purchase shares of various entities, including special purpose acquisition companies and/or other privately-held or publicly-traded entities (each, an “Investee,” and such purchases, the “Investments”). During the year ended December 31, 2022, the Company purchased shares for a total investment of $124.5 million. No Investments were purchased under such Investment Agreements during the fiscal year ended December 31, 2023.
In connection with signing the Investment Agreements, each Investee or an associated entity and the Company entered into a commercial contract for access to the Company’s products and services (collectively, the “Strategic Commercial Contracts”). The Company assesses the concurrent agreements under the noncash and consideration paid or payable to a customer guidance within ASC 606, Revenue from Contracts with Customers, as well as the commercial substance of each arrangement considering the customer’s ability and intention to pay as well as the Company’s obligation to perform under each contract. As currently assessed, the total value of Strategic Commercial Contracts was $376.5 million as of December 31, 2023, which is inclusive of $40.4 million of contractual options. The original terms of the Strategic Commercial Contracts with remaining deal value as of December 31, 2023, including contractual options, range from two years to seven years and are subject to termination for cause provisions. The Company performs ongoing assessments of customers’ financial condition, including the consideration of customers’ ability and intention to pay, and whether all or some portion of the value of such contracts continue to meet the criteria for revenue recognition, among other factors. As of December 31, 2023, the cumulative amount of revenue recognized from Strategic Commercial Contracts was $253.9 million, of which $87.3 million of revenue was recognized during the year ended December 31, 2023.
Alternative Investments
During the year ended December 31, 2021, the Company purchased $50.9 million in 100-ounce gold bars. During the year ended December 31, 2023, the Company sold all of its gold bars for total proceeds of $51.1 million and recorded an immaterial realized gain within other income (expense), net in the consolidated statements of operations.
v3.24.0.1
Balance Sheet Components
 12 Months Ended
Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]  
 Balance Sheet Components Balance Sheet Components
Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
As of December 31,
20232022
Leasehold improvements$83,139 $80,378 
Computer equipment, software, and other50,844 52,688 
Furniture and fixtures13,834 13,010 
Construction in progress2,099 5,506 
Total property and equipment, gross149,916 151,582 
Less: accumulated depreciation and amortization(102,158)(82,412)
Total property and equipment, net$47,758 $69,170 
Depreciation and amortization expense related to property and equipment, net was $23.7 million, $19.5 million, and $12.8 million for the years ended December 31, 2023, 2022, and 2021, respectively.
Accrued Liabilities
Accrued liabilities consisted of the following (in thousands):
As of December 31,
20232022
Accrued payroll and related expenses$83,094 $43,495 
Accrued taxes47,257 41,326 
Accrued other liabilities92,640 87,894 
Total accrued liabilities$222,991 $172,715 
v3.24.0.1
Debt
 12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Debt Debt
2014 Credit Facility
In October 2014, the Company entered into an unsecured revolving credit facility, which has been subsequently secured by substantially all of the Company’s assets and amended from time to time (as amended, the “2014 Credit Facility”). As of December 31, 2023, the Company had no outstanding debt balances and had undrawn revolving commitments of $500.0 million available to fund working capital and general corporate expenditures under the 2014 Credit Facility, which has a maturity date of March 31, 2027.
The 2014 Credit Facility contains customary representations and warranties, and certain financial and nonfinancial covenants, including but not limited to maintaining minimum liquidity of $50.0 million, and certain limitations on liens and indebtedness. The Company was in compliance with all covenants associated with the 2014 Credit Facility as of December 31, 2023.
v3.24.0.1
Leases
 12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Leases Leases
The Company has operating leases primarily for corporate office space and equipment. Certain lease agreements contain renewal options, rent abatement, and escalation clauses that are factored into our determination of lease payments when appropriate. The Company's leases have remaining terms up to December 2033, some of which include one or more options to extend. Additionally, some lease contracts include termination options.
Supplemental balance sheet information related to lease liabilities at December 31, 2023 and 2022 was as follows (in thousands):
As of December 31,
Lease-Related Assets and LiabilitiesFinancial Statement Line Items20232022
Right-of-use assets:
Operating leasesOperating lease right-of-use assets$182,863 $200,240 
Total right-of-use assets$182,863 $200,240 
Lease liabilities:
Operating leasesOperating lease liabilities$54,176 $45,099 
Operating lease liabilities, noncurrent175,216 204,305 
Total lease liabilities$229,392 $249,404 
The components of lease expense included in the Company's consolidated statements of operations include (in thousands):
Years Ended December 31,
20232022
Operating lease expense$61,972 $55,483 
Short-term lease expense4,949 4,956 
Variable lease expense4,772 5,309 
Sublease income(18,905)(13,011)
Total lease expense, net$52,788 $52,737 
Variable lease costs are primarily related to payments made to lessors for common area maintenance, property taxes, insurance, and other operating expenses. Short-term lease costs primarily represent temporary employee housing.
Maturities of operating lease liabilities as of December 31, 2023 were as follows (in thousands):
As of December 31, 2023
Operating Lease CommitmentsLess: Sublease IncomeNet Lease Commitments
Year ended December 31,
2024$67,420 $16,593 $50,827 
202557,053 14,357 42,696 
202640,068 13,748 26,320 
202728,278 14,423 13,855 
202821,816 12,470 9,346 
Thereafter62,116 30,761 31,355 
Total undiscounted liabilities276,751 102,352 174,399 
Less: Imputed interest(47,359)— (47,359)
Total operating lease liabilities$229,392 $102,352 $127,040 
The weighted-average remaining lease term related to the Company’s operating lease liabilities as of December 31, 2023 and 2022 was six years and seven years, respectively. The weighted-average discount rate related to the Company’s operating lease liabilities as of December 31, 2023 and 2022 was 6%.
The following table sets forth the supplemental information related to the Company's operating leases for the years ended December 31, 2023 and 2022 (in thousands):
Years Ended December 31,
20232022
Cash paid for operating lease liabilities$63,374 $53,772 
Lease liabilities arising from obtaining right-of-use assets
$28,112 $28,169 
As of December 31, 2023, the Company has no additional operating leases for office space that have not yet commenced.
Leases Leases
The Company has operating leases primarily for corporate office space and equipment. Certain lease agreements contain renewal options, rent abatement, and escalation clauses that are factored into our determination of lease payments when appropriate. The Company's leases have remaining terms up to December 2033, some of which include one or more options to extend. Additionally, some lease contracts include termination options.
Supplemental balance sheet information related to lease liabilities at December 31, 2023 and 2022 was as follows (in thousands):
As of December 31,
Lease-Related Assets and LiabilitiesFinancial Statement Line Items20232022
Right-of-use assets:
Operating leasesOperating lease right-of-use assets$182,863 $200,240 
Total right-of-use assets$182,863 $200,240 
Lease liabilities:
Operating leasesOperating lease liabilities$54,176 $45,099 
Operating lease liabilities, noncurrent175,216 204,305 
Total lease liabilities$229,392 $249,404 
The components of lease expense included in the Company's consolidated statements of operations include (in thousands):
Years Ended December 31,
20232022
Operating lease expense$61,972 $55,483 
Short-term lease expense4,949 4,956 
Variable lease expense4,772 5,309 
Sublease income(18,905)(13,011)
Total lease expense, net$52,788 $52,737 
Variable lease costs are primarily related to payments made to lessors for common area maintenance, property taxes, insurance, and other operating expenses. Short-term lease costs primarily represent temporary employee housing.
Maturities of operating lease liabilities as of December 31, 2023 were as follows (in thousands):
As of December 31, 2023
Operating Lease CommitmentsLess: Sublease IncomeNet Lease Commitments
Year ended December 31,
2024$67,420 $16,593 $50,827 
202557,053 14,357 42,696 
202640,068 13,748 26,320 
202728,278 14,423 13,855 
202821,816 12,470 9,346 
Thereafter62,116 30,761 31,355 
Total undiscounted liabilities276,751 102,352 174,399 
Less: Imputed interest(47,359)— (47,359)
Total operating lease liabilities$229,392 $102,352 $127,040 
The weighted-average remaining lease term related to the Company’s operating lease liabilities as of December 31, 2023 and 2022 was six years and seven years, respectively. The weighted-average discount rate related to the Company’s operating lease liabilities as of December 31, 2023 and 2022 was 6%.
The following table sets forth the supplemental information related to the Company's operating leases for the years ended December 31, 2023 and 2022 (in thousands):
Years Ended December 31,
20232022
Cash paid for operating lease liabilities$63,374 $53,772 
Lease liabilities arising from obtaining right-of-use assets
$28,112 $28,169 
As of December 31, 2023, the Company has no additional operating leases for office space that have not yet commenced.
v3.24.0.1
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Purchase Commitments
In September 2023, the Company amended one of its third-party cloud hosting services agreements. Under this amendment, the Company has a commitment to spend at least $1.95 billion over ten contract years through September 30, 2033, as well as certain additional minimum usage commitments, among other things. Any and all previous payment obligations related to such third-party cloud hosting services agreement were terminated concurrently with the signing of this amendment. As of December 31, 2023, the Company had satisfied $40.7 million of the $154.0 million commitment amount for the contract year beginning October 1, 2023 and ending September 30, 2024.
Litigation and Legal Proceedings
From time to time, third parties may assert patent infringement claims against the Company. In addition, from time to time, the Company may be subject to other legal proceedings and claims in the ordinary course of business, including claims of alleged infringement of trademarks, copyrights, and other intellectual property rights; employment claims; securities claims; investor claims; corporate claims; class action claims; and general contract, tort, or other claims. The Company may from time to time also be subject to various legal or government claims, disputes, or investigations. Such matters may include, but not be limited to, claims, disputes, allegations, or investigations related to warranty; refund; breach of contract; breach, leak, or misuse of personal data or confidential information; employment; government procurement; intellectual property; government regulation or compliance (including but not limited to anti-corruption requirements, export or other trade controls, data privacy or data protection, cybersecurity requirements, or antitrust/competition law requirements); securities; investor; corporate; or other matters. The Company establishes an accrual for loss contingencies when the loss is both probable and reasonably estimable.
On September 15, 2022, October 25, 2022, and November 4, 2022, putative securities class action complaints were filed in the United States District Court for the District of Colorado, captioned Cupat v. Palantir Technologies Inc., et al., Case No. 1:22-cv-02384, Allegheny County Employees’ Retirement System v. Palantir Technologies, Inc., et al., Case No. 1:22-cv-02805, and Shijun Liu, Individually and as Trustee of the Liu Family Trust 2019 v. Palantir Technologies Inc., et al., Case No. 1:22-cv-02893, respectively, naming the Company and certain current and former officers and directors as defendants. The suits allege false and misleading statements about our business and prospects, and purport to allege claims under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Securities Act of 1933, as amended (the “Securities Act”), and seek unspecified damages and remedies under Sections 10(b), 20(a), and 20(A) of the Exchange Act and Sections 11 and 15 of the Securities Act. These three actions subsequently were consolidated as Cupat v. Palantir Technologies Inc., et al., Lead Civil Action No. 1:22-cv-02834-CNS-SKC, consolidated with civil actions 1:22-cv-02805-CNS-SKC and 1:22-cv-02893-CNS-SKC. On November 21, 2022 and January 13, 2023, stockholder derivative actions were filed in the United States District Court for the District of Colorado, captioned Li v. Karp, et al., Case No. 22-cv-3028 and Parmenter v. Karp, et al., Case No. 23-cv-118, and on January 27, 2023, a stockholder derivative action was filed in the United States District Court for the District of Delaware captioned Miao v. Karp, et al., Case No. 1:23-cv-00103-MN, each against certain current and former officers and directors asserting breach of fiduciary duty and related claims relating to the allegations of the securities class action complaints and seek unspecified damages and injunctive remedies under Section 14(a) of the Exchange Act and Delaware law. On August 22, 2023, a stockholder derivative action was filed in the Court of Chancery of the State of Delaware captioned Central Laborers’ Pension Fund v. Karp, et al., Case No. 2023-0864 against certain current and former officers and directors asserting breach of fiduciary duty and related claims relating to the allegations of the securities class action complaints and seeks unspecified damages and injunctive relief under Delaware law. Because the litigation is in early stages, the Company is unable to estimate the reasonably possible loss or range of loss, if any, that may result from these matters. On November 20, 2023, the plaintiff in Parmenter v. Karp, et al., Case No. 23-cv-118, filed a Notice of Voluntary Dismissal. On November 28, 2023, the court terminated the Parmenter action accordingly.
As of December 31, 2023, the Company was not aware of any currently pending legal matters or claims, individually or in the aggregate, that are expected to have a material adverse impact on its consolidated financial statements.
Warranties and Indemnification
The Company generally provides a warranty for its software products and services and a service level agreement (“SLA”) for the Company’s performance of software operations. The Company’s products are generally warranted to perform substantially as described in the associated product documentation during the subscription term or for a period of up to 90 days where the software is hosted by the customer, and the Company includes O&M services as part of its subscription and license agreements to support this warranty and maintain the operability of the software. The Company’s services are generally warranted to be performed in a professional manner and by an adequate staff with knowledge about the products. In the event there is a failure of such warranties, the Company generally is obligated to correct the product or service to conform to the warranty provision or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product and service (generally prorated over the contract term). Due to the absence of historical warranty claims, the Company’s expectations of future claims related to products under warranty continue to be insignificant. The Company has not recorded warranty expense or related accruals as of December 31, 2023 and 2022.
The Company generally agrees to indemnify its customers against legal claims that the Company’s software products infringe certain third-party intellectual property rights and accounts for its indemnification obligations. In the event of such a claim, the Company is generally obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of an infringement, the Company generally agrees to secure the right for the customer to continue using the infringing product; to modify or replace the infringing product; or, if those options are not commercially practicable, to refund the cost of the software, as prorated over the period. To date, the Company has not been required to make any payment resulting from
infringement claims asserted against its customers and does not believe that the Company will be liable for such claims in the foreseeable future. As such, the Company has not recorded a liability for infringement costs as of December 31, 2023 and 2022.
The Company has obligations under certain circumstances to indemnify each of the defendant directors and certain officers against judgments, fines, settlements, and expenses related to claims against such directors and certain officers and otherwise to the fullest extent permitted under the law and the Company’s Amended and Restated Bylaws and Amended and Restated Certificate of Incorporation.
v3.24.0.1
Stockholders' Equity
 12 Months Ended
Dec. 31, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
9. Stockholders’ Equity
The Company’s Class A, Class B, and Class F common stock (collectively, the “common stock”) all have the same rights, except with respect to voting and conversion rights. Class A and Class B common stock have voting rights of 1 and 10 votes per share, respectively. The Class F common stock has the voting rights generally described herein and each share of Class F common stock is convertible at any time, at the option of the holder thereof, into one share of Class B common stock. All shares of Class F common stock are held in a voting trust established by Stephen Cohen, Alexander Karp, and Peter Thiel (the “Founders”). The Class F common stock generally gives the Founders the ability to control up to 49.999999% of the total voting power of the Company’s capital stock, so long as the Founders and certain of their affiliates collectively meet a minimum ownership threshold, which was 100.0 million of the Company's equity securities as of December 31, 2023.
Holders of the common stock are entitled to dividends when, as, and if declared by the Company’s Board of Directors, subject to the rights of the holders of all classes of stock outstanding having priority rights to dividends. No dividends have been declared as of December 31, 2023.
The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands):
As of December 31, 2023As of December 31, 2022
AuthorizedIssued and OutstandingAuthorizedIssued and Outstanding
Class A Common Stock20,000,000 2,096,982 20,000,000 1,995,414 
Class B Common Stock2,700,000 102,141 2,700,000 102,656 
Class F Common Stock1,005 1,005 1,005 1,005 
Total22,701,005 2,200,128 22,701,005 2,099,075 
Share Repurchase Program
In August 2023, the Company’s Board of Directors authorized a stock repurchase program of up to $1.0 billion of the Company’s outstanding shares of Class A common stock (the “Share Repurchase Program”). The Company may repurchase shares of its Class A common stock from time to time through open market purchases, in privately negotiated transactions, or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Exchange Act in accordance with applicable securities laws and other restrictions. The timing and the amount of stock repurchases under the Share Repurchase Program will be determined by the Company’s management, based on its evaluation of factors including business and market conditions, corporate and regulatory requirements, and other considerations. The Share Repurchase Program does not obligate the Company to repurchase any specific number of shares and may be discontinued at any time. During the year ended December 31, 2023, the Company did not repurchase any shares of its Class A common stock under the Share Repurchase Program.
v3.24.0.1
Stock-Based Compensation
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
2020 Executive Equity Incentive Plan
In August 2020, the Company’s Board of Directors approved the 2020 Executive Equity Incentive Plan (the “Executive Equity Plan”). The Executive Equity Plan permitted the granting of nonstatutory stock options (“NSOs”) and RSUs to the Company’s employees, consultants, and directors. A total of 165,900,000 shares of the Company’s Class B common stock were reserved for issuance under the Executive Equity Plan. During August 2020, options to purchase 162,000,000 shares of Class B common
stock and restricted stock units covering 3,900,000 shares of the Company’s Class B common stock were granted to certain officers.
The Executive Equity Plan was terminated prior to the Company’s Direct Listing, and no additional awards will be granted under the Executive Equity Plan. However, the Executive Equity Plan will continue to govern the terms and conditions of the outstanding awards previously granted under the Executive Equity Plan.
2020 Equity Incentive Plan
In September 2020, prior to the Direct Listing, the Company’s Board of Directors approved the 2020 Equity Incentive Plan (“2020 Plan”). The 2020 Plan provides for the grant of incentive stock options (“ISOs”), NSOs, restricted stock, RSUs, stock appreciation rights (“SARs”), and performance awards to the Company’s employees, directors, and consultants. A total of 150,000,000 shares of the Company’s Class A common stock were initially reserved for issuance pursuant to the 2020 Plan. In addition, the number of shares of Class A common stock reserved for issuance under the 2020 Plan includes certain shares of common stock subject to awards under the 2010 Equity Incentive Plan (“2010 Plan”) and Executive Equity Plan in the case of certain occurrences, such as expirations, terminations, exercise and tax-related withholding, or failures to vest. Shares of Class B common stock added to the 2020 Plan from the 2010 Plan or Executive Equity Plan are reserved for issuance under the Company’s 2020 Plan as Class A common stock. The number of shares of Class A common stock available for issuance under the 2020 Plan will also include an annual increase on the first day of each fiscal year beginning on January 1, 2022, equal to the least of:
•250,000,000 shares of the Company’s Class A common stock;
•Five percent of the outstanding shares of the Company’s common stock as of the last day of the immediately preceding fiscal year; or
•such other amount as the administrator of the 2020 Plan determines.
Under the 2020 Plan, the exercise price of options granted is generally at least equal to the fair market value of the Company’s Class A common stock on the date of grant. The term of an ISO generally may not exceed ten years. Additionally, the exercise price of any ISO granted to a 10% stockholder shall not be less than 110% of the fair market value of the common stock on the date of grant, and the term of such option grant shall not exceed five years. Options and other equity awards become vested and, if applicable, exercisable based on terms determined by the Board of Directors or another plan administrator on the date of grant, which is typically four years for new employees and varies for subsequent grants.
Stock Options
The following table summarizes stock option activity for the year ended December 31, 2023 (in thousands, except per share amounts):
Options Outstanding
Weighted-Average Exercise Price Per Share
Weighted-Average
Remaining Contractual Life (years)
Aggregate Intrinsic Value
Balance as of December 31, 2022326,913 $8.05 8.33$272,603 
Options exercised(46,079)4.74 
Options canceled and forfeited(2,364)5.39 
Balance as of December 31, 2023278,470 $8.62 7.64$2,381,172 
Options vested and exercisable as of December 31, 2023160,877 $6.66 6.93$1,691,404 
The aggregate intrinsic value of options outstanding, and vested and exercisable is calculated as the difference between the exercise price of the underlying options and the fair value of the Company’s common stock as of December 31, 2023. The aggregate intrinsic value of options exercised during the years ended December 31, 2023, 2022, and 2021 was $476.8 million, $112.3 million, and $3.8 billion, respectively, and is calculated based on the difference between the exercise price and the fair value of the Company’s common stock on the exercise date.
There were no options granted during the years ended December 31, 2023, 2022, and 2021. The total grant-date fair value of options that vested during the years ended December 31, 2023, 2022, and 2021 was $131.0 million, $170.8 million, and $189.5
million, respectively.
As of December 31, 2023, the total unrecognized stock-based compensation expense related to options outstanding was $599.1 million, which is expected to be recognized over a weighted-average service period of seven years.
RSUs and P-RSUs
The following table summarizes the RSU and P-RSU activity for the year ended December 31, 2023 (in thousands, except per share amounts):
RSUsP-RSUs
Units OutstandingWeighted Average Grant Date Fair Value per ShareUnits OutstandingWeighted Average Grant Date Fair Value per Share
Unvested and outstanding as of December 31, 2022126,426 $10.07 — $— 
Granted19,484 11.77 1,976 15.39 
Vested(54,974)9.57 — — 
Canceled(8,674)11.08 — — 
Unvested and outstanding as of December 31, 202382,262 $10.71 1,976 $15.39 
During the fiscal year ended December 31, 2023, the Company granted RSUs that have only a service-based vesting condition, as well as those that have both service-based and performance-based vesting conditions (“P-RSUs”). The service-based vesting condition for each is generally satisfied upon continued service through a specified date. Vesting periods for the RSUs and P-RSUs are generally up to 4 years and three months, respectively. The performance-based vesting condition is satisfied upon the achievement of certain Company performance goals set by the Compensation Committee of the Board of Directors. The ultimate number of P-RSUs earned and eligible to vest ranges between 0% to 100% of the target number of P-RSUs granted depending on the level of achievement of such Company performance goals.
The total grant-date fair value of RSUs vested during the years ended December 31, 2023, 2022, and 2021 was $526.1 million, $453.2 million, and $421.0 million, respectively. As of December 31, 2023, the total unrecognized stock-based compensation expense related to the RSUs outstanding was $566.4 million, which is expected to be recognized over a weighted-average service period of three years. As of December 31, 2023, there was no unrecognized stock-based compensation expense related to the P-RSUs outstanding.
Stock-based Compensation Expense
Total stock-based compensation expense was as follows (in thousands):
Years Ended December 31,
202320222021
Cost of revenue$35,995 $44,061 $68,546 
Sales and marketing160,645 196,301 242,910 
Research and development98,064 93,871 150,298 
General and administrative181,199 230,565 316,461 
Total stock-based compensation expense$475,903 $564,798 $778,215 
The Company did not recognize any tax benefits related to stock-based compensation expense during the years ended December 31, 2023, 2022, or 2021.
v3.24.0.1
Income Taxes
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Income (loss) before provision for income taxes consisted of the following (in thousands):
Years Ended December 31,
202320222021
United States$174,637 $(402,834)$(514,200)
Foreign62,454 41,807 25,706 
Income (loss) before provision for income taxes$237,091 $(361,027)$(488,494)
Provision for income taxes consisted of the following (in thousands):
Years Ended December 31,
202320222021
Current:
Federal$— $— $— 
State2,333 765 (88)
Foreign22,189 9,476 (11,343)
Total current provision24,522 10,241 (11,431)
Deferred:
Federal— — (111)
State— — — 
Foreign(4,806)(174)43,427 
Total deferred provision(4,806)(174)43,316 
Total provision for income taxes$19,716 $10,067 $31,885 
A reconciliation of the expected tax provision at the statutory federal income tax rate to the Company’s recorded tax provision consisted of the following (in thousands):
Years Ended December 31,
202320222021
Expected tax (benefit) at U.S. federal statutory rate$49,789 $(75,592)$(102,584)
State income taxes - net of federal benefit2,309 766 (88)
Foreign tax rate differential859 832 870 
Research and development tax credits(45,667)(34,546)(94,591)
Stock-based compensation(79,128)1,374 (817,839)
Non-deductible officers’ compensation
34,479 40,629 428,682 
Change in valuation allowance35,070 49,833 616,572 
Base Erosion Anti-Abuse Tax and related elections14,700 25,200 — 
Taxes withheld at source4,378 — — 
Non-deductible expenses3,610 — — 
Other(683)1,571 863 
Total provision for income taxes$19,716 $10,067 $31,885 
For the year ended December 31, 2023, the Company recorded a provision for income taxes of $19.7 million compared to $10.1 million for the year ended December 31, 2022, primarily due to the increase in foreign income taxes as the result of higher foreign taxable income and higher foreign withholding taxes in the current year. The Company maintains a full valuation allowance against its U.S. federal and state, and certain foreign deferred tax assets.
For the year ended December 31, 2022, the Company recorded a provision for income taxes of $10.1 million compared to $31.9 million for the year ended December 31, 2021, primarily due to the prior year establishment of a full valuation allowance
against its U.K. deferred tax assets during the fourth quarter of 2021 partially offset by permanent differences associated with U.S. Base Erosion and Anti Abuse Tax elections. The Company maintains a full valuation allowance against its U.S. federal and state and certain foreign deferred tax assets.
Deferred tax assets and liabilities are recognized for the future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax basis using enacted tax rates in effect for the year in which the differences are expected to reverse. Significant deferred tax assets and liabilities consisted of the following (in thousands):
As of December 31,
20232022
Net operating loss carryforwards$1,317,684 $1,436,957 
Capitalized research and experimental expenses214,848 70,839 
Reserves and accruals99,105 76,905 
Tax credit carryforwards277,060 226,565 
Stock-based compensation139,419 203,735 
Lease liabilities53,902 58,056 
Depreciation and amortization14,413 29,665 
Capitalized facilitative expenses28,906 — 
Gross deferred tax assets2,145,337 2,102,722 
Outside basis difference— (6,512)
Acquisition related intangibles(8,428)(10,225)
Right-of-use assets(42,721)(46,295)
Total net deferred tax assets before valuation allowance2,094,188 2,039,690 
Valuation allowance(2,102,251)(2,051,655)
Net deferred tax assets (liabilities)$(8,063)$(11,965)
Because of the Company’s history of U.S. and certain foreign net operating tax losses, primarily in the U.K., the Company has maintained a full valuation allowance against potential future benefits for U.S, federal, state, and certain foreign deferred tax assets as of December 31, 2023.
The valuation allowance totaled $2.1 billion for the years ended December 31, 2023 and 2022. The valuation allowance on our net deferred tax assets increased by $50.6 million and $74.1 million during the years ended December 31, 2023 and 2022, respectively.
Provisions enacted by the 2017 Tax Cuts and Jobs Act related to the capitalization for tax purposes of research and experimental (“R&E”) expenditures became effective on January 1, 2022. All U.S. and foreign based R&E expenditures must be capitalized and amortized over five years and 15 years, respectively. As a result of this enactment, the Company began capitalizing and amortizing R&E expenditures over five years for domestic research and 15 for foreign research rather than expensing these costs as incurred during fiscal year ended December 31, 2022. The Company has recorded a deferred tax asset of $214.8 million as of December 31, 2023 related to the capitalization requirement.
As of December 31, 2023, the Company had U.S. federal and state net operating losses of approximately $5.0 billion and $2.5 billion, respectively. As of December 31, 2022, the Company had U.S. federal and state net operating losses of approximately $5.6 billion and $2.8 billion, respectively. The U.S. federal net operating loss carryforwards will expire at various dates beginning in 2035 through 2037 if not utilized, with the exception of $4.2 billion which can be carried forward indefinitely. The state net operating loss carryforwards will expire at various dates beginning in 2025 through 2043 if not utilized.
Additionally, as of December 31, 2023, the Company had federal and California research and development credits of approximately $290.1 million and $99.5 million, respectively. As of December 31, 2022, the Company had federal and California research and development credits of approximately $230.2 million and $91.4 million, respectively. The federal research and development credits will begin to expire in the years 2027 through 2043 if not utilized and the California research and development credits have no expiration date. Utilization of the net operating losses and research and development credit carryforwards may be subject to an annual limitation due to the ownership percentage change limitations provided by the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of the net operating loss and research and development credit carryforwards before utilization.
As of December 31, 2023, the Company had U.S. federal capital loss carryforwards of $324.0 million. As of December 31, 2022, the Company had U.S. federal capital loss carryforwards of $113.1 million. The capital loss carryforwards will expire beginning in 2027 if not utilized.
As of December 31, 2023, the Company had foreign net operating losses, primarily in the U.K., of approximately $464.7 million. These net operating losses can be carried forward indefinitely.
As of December 31, 2023, the Company had an immaterial amount of earnings from its wholly-owned foreign subsidiaries indefinitely reinvested outside the U.S. The Company does not intend to repatriate these earnings and, accordingly, the Company does not provide for U.S. income taxes and foreign withholding tax on these earnings.
On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, the Company does not believe this legislation will have a material impact on its consolidated financial statements.
Uncertain Tax Positions
A reconciliation of the gross unrecognized tax benefits consists of the following (in thousands):
Years Ended December 31,
202320222021
Unrecognized tax benefit beginning of year$81,904 $65,070 $75,557 
Increases in current year tax positions14,346 5,733 19,638 
Increases in prior year tax positions15,766 11,497 967 
Decreases in prior year tax positions— (36)(30,895)
Decreases in prior year tax positions due to settlements— (360)(197)
Decreases in prior year tax positions due to lapse of statute of limitations— — — 
Unrecognized tax benefit end of year$112,016 $81,904 $65,070 
As of December 31, 2023, 2022, and 2021, the Company recorded gross unrecognized tax benefits of $112.0 million, $81.9 million, and $65.1 million, respectively, that, if recognized, would not benefit the Company’s effective tax rate due to the valuation allowance that currently offsets deferred tax assets.
As of December 31, 2023, no significant increases or decreases are expected to the Company’s uncertain tax positions within the next twelve months.
It is the Company’s policy to recognize interest and penalties related to income tax matters in provision for income taxes on the consolidated statements of operations. The Company has recorded immaterial interest and penalties related to uncertain tax positions as of December 31, 2023, 2022, and 2021.
The Company files U.S. federal, state, and foreign income tax returns in jurisdictions with varying statutes of limitation. The material jurisdictions where the Company is subject to potential examination by tax authorities are the U.S. (federal and state) for tax years 2004 through 2023 and the U.K. for tax years 2017 through 2023.
v3.24.0.1
Net Earnings (Loss) Per Share Attributable to Common Stockholders
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Net Earnings (Loss) Per Share Attributable to Common Stockholders Net Earnings (Loss) Per Share Attributable to Common Stockholders
The following table presents the calculation of basic and diluted net earnings (loss) per share attributable to common stockholders (in thousands, except share and per share amounts):
As of December 31,
202320222021
Numerator
Net income (loss) attributable to common stockholders for diluted net earnings (loss) per share$209,825 $(373,705)$(520,379)
Denominator
Weighted-average shares used in computing net earnings (loss) per share:
Basic2,147,446 2,063,793 1,923,617 
Effect of dilutive shares150,481 — — 
Diluted2,297,927 2,063,793 1,923,617 
Net earnings (loss) per share
Net earnings (loss) per share attributable to common stockholders:
Basic$0.10 $(0.18)$(0.27)
Diluted$0.09 $(0.18)$(0.27)
The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net earnings (loss) per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands):
As of December 31,
202320222021
Options and SARs issued and outstanding162,000 326,913 349,977 
RSUs and P-RSUs outstanding13,245 126,426 153,749 
Warrants to purchase common stock— 13,042 13,042 
Total175,245 466,381 516,768 
v3.24.0.1
Segment and Geographic Information
 12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Segment and Geographic Information Segment and Geographic Information
The following reporting segment tables reflect the results of the Company’s reportable operating segments consistent with the manner in which the CODM evaluates the performance of each segment and allocates the Company’s resources. The CODM does not evaluate the performance of the Company’s assets on a segment basis for internal management reporting and, therefore, such information is not presented.
Contribution is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. A segment’s contribution is calculated as segment revenue less the related costs of revenue and sales and marketing expenses. It excludes certain operating expenses that are not allocated to segments because they are separately managed at the consolidated corporate level, or are noncash costs. These unallocated and noncash costs include stock-based compensation expense, research and development expenses, and general and administrative expenses.
Financial information for each reportable segment was as follows (in thousands):
Years Ended December 31,
202320222021
Revenue:
Government$1,222,215 $1,071,776 $897,356 
Commercial1,002,797 834,095 644,533 
Total revenue$2,225,012 $1,905,871 $1,541,889 
Years Ended December 31,
202320222021
Amount%Amount%Amount%
Contribution:
Government$724,970 59 %$620,677 58 %$541,883 60 %
Commercial520,585 52 %414,496 50 %357,546 55 %
Total contribution$1,245,555 56 %$1,035,173 54 %$899,429 58 %
The reconciliation of contribution to income (loss) from operations is as follows (in thousands):
Years Ended December 31,
202320222021
Income (loss) from operations
$119,966 $(161,201)$(411,046)
Research and development expenses (1)
306,560 265,808 237,189 
General and administrative expenses (1)
343,126 365,768 295,071 
Total stock-based compensation expense475,903 564,798 778,215 
Total contribution$1,245,555 $1,035,173 $899,429 
—————
(1) Excludes stock-based compensation expense.
Geographic Information
Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages):
Years Ended December 31,
202320222021
Amount%Amount%Amount%
Revenue:
United States$1,378,247 62 %$1,161,416 61 %$879,156 57 %
United Kingdom235,257 11 %220,942 12 %173,362 11 %
Rest of world (1)
611,508 27 %523,513 27 %489,371 32 %
Total revenue$2,225,012 100 %$1,905,871 100 %$1,541,889 100 %
—————
(1) No other country represented 10% or more of total revenue for the years ended December 31, 2023, 2022, or 2021.
Property and equipment, net is attributed to the Company’s office locations as follows (in thousands, except percentages):
As of December 31,
20232022
Amount%Amount%
Property and equipment, net:
United States$28,825 60 %$46,599 67 %
Japan11,440 24 %13,318 19 %
United Kingdom5,851 12 %6,746 10 %
Rest of world1,642 4 %2,507 4 %
Total property and equipment, net$47,758 100 %$69,170 100 %
v3.24.0.1
Business Combinations
 12 Months Ended
Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
Business Combinations Business Combinations
On November 8, 2022, the Company gained the right to majority representation on the board of directors of Palantir Japan, thereby obtaining a controlling interest. Prior to obtaining a controlling interest, the Company accounted for its 50% ownership in Palantir Japan as an equity method investment, which was created to distribute Palantir platforms to the Japanese market. This transaction was accounted for as a “step acquisition” (as defined by U.S. GAAP), as such, the Company remeasured its pre-existing equity interest in Palantir Japan immediately prior to the completion of the acquisition to its estimated fair value. The results of Palantir Japan have been included in the Company’s consolidated financial statements since the acquisition date, with the portion outside of its control forming a noncontrolling interest.
The fair value of Palantir Japan on the acquisition date totaled $149.0 million, which included the Company’s equity interest immediately prior to the acquisition of $74.5 million and the noncontrolling interest of $74.5 million. The amounts recognized of assets acquired and liabilities assumed as of the acquisition date included: cash of $66.7 million; goodwill of $36.1 million; intangible assets of $34.7 million related to customer relationships, reacquired rights, and backlog; $32.5 million of other identifiable assets; and $21.0 million of net liabilities. The intangible assets are reported in other assets and are being amortized over a period of two to seven years in accordance with the underlying pattern of economic benefit reflected by the future net cash flows. Goodwill is reported in other assets and is primarily attributed to the value expected from synergies resulting from the Palantir Japan acquisition. None of the goodwill recognized is expected to be deductible for income tax purposes.
In accordance with accounting for a step acquisition, the Company recognized a gain of $44.3 million during the year ended December 31, 2022 as a result of remeasuring its pre-existing interest in Palantir Japan held immediately before the business combination, which was included in other income (expense), net in the consolidated statements of operations.
v3.24.0.1
Intangible Assets
 12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets Intangible Assets
Intangible assets subject to amortization that are not fully amortized are as follows (in thousands):
Weighted average useful lifeAs of December 31, 2023As of December 31, 2022
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Customer relationships3.83$10,400 $(2,427)$7,973 $10,400 $(347)$10,053 
Reacquired rights5.8317,618 (2,936)14,682 17,619 (420)17,199 
Backlog0.836,700 (3,908)2,792 6,700 (558)6,142 
Other0.274,225 (3,770)455 5,717 (3,572)2,145 
Total intangible assets$38,943 $(13,041)$25,902 $40,436 $(4,897)$35,539 
Amortization expense of intangible assets was $9.6 million and not material for the years ended December 31, 2023 and 2022, respectively.
As of December 31, 2023, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows (in thousands):
Year ended December 31,Amount
2024$7,844 
20254,597 
20264,597 
20274,250 
20282,517 
Thereafter2,097 
Total$25,902 
v3.24.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Pay vs Performance Disclosure      
Net Income (Loss) $ 209,825 $ (373,705) $ (520,379)
v3.24.0.1
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Dec. 31, 2023
shares
Dec. 31, 2023
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Alexander Moore [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On November 30, 2023, Alexander Moore, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement providing for the potential sales of shares of our Class A common stock through various transactions upon the occurrence and
satisfaction of certain price and/or other conditions, with 257,499 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The duration of the trading arrangement is until February 28, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement.
Name Alexander Moore  
Title member of our Board of Directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date November 30, 2023  
Arrangement Duration 456 days  
Aggregate Available 257,499 257,499
Eric Woersching [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On December 8, 2023, Eric Woersching, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement providing for the potential sales of shares of our Class A common stock through various transactions upon the occurrence and satisfaction of certain price and/or other conditions, with 35,026 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The duration of the trading arrangement is until June 6, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement.
Name Eric Woersching  
Title member of our Board of Directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 8, 2023  
Arrangement Duration 546 days  
Aggregate Available 35,026 35,026
David Glazer [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On December 12, 2023, David Glazer, our Chief Financial Officer and Treasurer, adopted a Rule 10b5-1 trading arrangement providing for the potential sales of shares of our Class A common stock through various transactions upon the occurrence and satisfaction of certain price and/or other conditions, with 1,479,169 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The duration of the trading arrangement is until September 11, 2024, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement.
Name David Glazer  
Title Chief Financial Officer and Treasurer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 12, 2023  
Arrangement Duration 274 days  
Aggregate Available 1,479,169 1,479,169
Alexander Karp [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On December 12, 2023, Alexander Karp, our Chief Executive Officer and a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement providing for the potential sales of shares of our Class A common stock through various transactions upon the occurrence and satisfaction of certain price and/or other conditions, with 48,900,000 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions, less any shares to be withheld and/or sold to satisfy applicable tax withholdings. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The duration of the trading arrangement is until June 1, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement.
Name Alexander Karp  
Title Chief Executive Officer and a member of our Board of Directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 12, 2023  
Arrangement Duration 537 days  
Aggregate Available 48,900,000 48,900,000
Rivendell 7 LLC Plan [Member] | Peter Thiel [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On December 12, 2023, Rivendell 7 LLC, a stockholder whose shares may be deemed to be beneficially owned by Peter Thiel (the Chairman of our Board of Directors), adopted a Rule 10b5-1 arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), subject to the satisfaction of certain price and/or other conditions, with 15,000,000 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. The duration of the trading arrangement is until March 12, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement.
Name Peter Thiel  
Title Chairman of our Board of Directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 12, 2023  
Arrangement Duration 456 days  
Aggregate Available 15,000,000 15,000,000
STS Holdings II LLC Plan [Member] | Peter Thiel [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On December 12, 2023, STS Holdings II LLC, a stockholder whose shares may be deemed to be beneficially owned by Peter Thiel (the Chairman of our Board of Directors), adopted a Rule 10b5-1 arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), subject to the satisfaction of certain price and/or other conditions, with 5,000,000 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. Trading under the arrangement is not authorized to begin until after all trades under the trading arrangement entered into by Rivendell 7 LLC described above are completed or expired without execution. The duration of the trading arrangement is until March 12, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement.
Name Peter Thiel  
Title Chairman of our Board of Directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 12, 2023  
Arrangement Duration 456 days  
Aggregate Available 5,000,000 5,000,000
v3.24.0.1
Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentation and Consolidation
Basis of Presentation and Consolidation
The accompanying consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding annual financial reporting. The accompanying consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over, but does not control, the investee are accounted for using the equity method of accounting. Certain prior year balances have been reclassified to conform to the current year presentation. Such reclassifications did not affect total revenues, income (loss) from operations, net income (loss), or cash flows. The Company’s fiscal year ends on December 31.
Use of Estimates
Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods.
Significant estimates and assumptions made in the accompanying consolidated financial statements include, but are not limited to, the identification of performance obligations in customer contracts, the valuation of deferred tax assets and uncertain tax positions, and the collectability of contract consideration, including accounts receivable. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations.
Segments
Segments
The Company has two operating segments, commercial and government, which were determined based on the manner in which the chief operating decision maker (“CODM”), who is the Chief Executive Officer, manages the operations of the Company for purposes of allocating resources and evaluating performance. Various factors, including the Company’s organizational and management reporting structure and customer type, were considered in determining these operating segments.
The Company’s operating segments are described below:
•Commercial: This segment primarily serves customers working in non-government industries.
•Government: This segment primarily serves customers that are United States (“U.S.”) government and non-U.S. government agencies.
Cash, Cash Equivalents, and Restricted Cash
Cash, Cash Equivalents, and Restricted Cash
The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds and available-for-sale debt securities.
Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the amounts shown in the consolidated statements of cash flows (in thousands):
As of December 31,
202320222021
Cash and cash equivalents$831,047 $2,598,540 $2,290,674 
Restricted cash included in prepaid expenses and other current assets370 16,244 36,628 
Restricted cash included in other assets18,690 12,551 39,612 
Total cash, cash equivalents, and restricted cash$850,107 $2,627,335 $2,366,914 
Accounts Receivable and Allowance for Credit Losses
Accounts Receivable and Allowance for Credit Losses
Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. The Company generally grants non-collateralized credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are written-off and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the Company’s assessment as of December 31, 2023 and 2022, the Company recorded an allowance for credit losses of $10.5 million and $10.1 million, respectively.
Debt Securities
Debt Securities
Debt securities are primarily comprised of U.S. treasury securities. The debt securities are classified as available-for-sale at the time of purchase and are reevaluated as of each balance sheet date. The Company considers the majority of its available-for-sale debt securities as available for use in current operations and may sell these securities at any time, and therefore classifies these securities as current assets in its consolidated balance sheets. Debt securities included in marketable securities on the consolidated balance sheets consist of U.S. treasury securities with original maturities of greater than three months at the time of purchase, and the remaining U.S. treasury securities are included in cash and cash equivalents. Interest income on debt securities is included in other income (expense), net on the consolidated statements of operations.
The majority of the Company’s available-for-sale securities are recorded at fair value each reporting period using quoted prices of similar instruments and are classified within Level 2 of the fair value hierarchy. The Company evaluates investments with unrealized loss positions for other than temporary impairment by assessing if they are related to deterioration in credit risk and whether it expects to recover the entire amortized cost basis of the security, the Company’s intent to sell, and whether it is more likely than not that the Company will be required to sell the securities before the recovery of their cost basis. Credit-related impairment losses, not to exceed the amount that fair value is less than the amortized cost basis, are recognized in other income (expense), net in the consolidated statements of operations. Unrealized gains and non-credit related losses are reported as a separate component of accumulated other comprehensive loss, net in the consolidated balance sheets until realized. Realized gains and losses and declines in value judged to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net in the consolidated statements of operations.
Concentrations of Credit Risk
Concentrations of Credit Risk
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, accounts receivable, marketable securities, and privately-held equity securities. Cash equivalents primarily consist of money market funds and U.S. treasury securities with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts.
The Company is exposed to concentrations of credit risk with respect to accounts receivable presented in the consolidated balance sheets. The Company’s accounts receivable balances as of December 31, 2023 and 2022 were $364.8 million and $258.3 million, respectively. Customer I represented 15% of total accounts receivable as of December 31, 2023, and no other customer represented more than 10% of total accounts receivable as of December 31, 2023. No customer represented more than 10% of total accounts receivable as of December 31, 2022. 
For the years ended December 31, 2023, 2022, and 2021, no customer represented 10% or more of total revenue.
Alternative Investments
Alternative Investments
Alternative investments include gold bars and are recorded in prepaid expenses and other current assets on the consolidated balance sheets. The investments are initially recorded at cost and subsequently remeasured at the lower of cost or market each reporting period. Market value is determined by using quoted market prices of identical or similar assets from active markets. Unrealized losses are recorded in other income (expense), net in the consolidated statements of operations. Realized gains and losses are recorded in other income (expense), net upon realization.
Property and Equipment, Net
Property and Equipment, Net
Property and equipment, net are stated at cost less accumulated depreciation and amortization. Depreciation is recognized using the straight-line method over the estimated useful lives of the respective assets, which are generally three years. Leasehold improvements are capitalized and amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful life, which is generally five years. Maintenance and repairs that do not improve or extend the useful lives of the assets are expensed when incurred. Upon sale or retirement of assets, the cost and related accumulated depreciation and amortization are derecognized from the consolidated balance sheets and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized.
Privately-held Equity Securities
Privately-held Equity Securities
Equity securities in privately-held companies without readily determinable fair values are recorded using the measurement alternative. Such investments are carried at cost, less any impairments, and are adjusted for subsequent observable price changes in orderly transactions for identical or similar investments of the same issuer. Changes in the basis of the equity securities are recognized in other income (expense), net in the consolidated statements of operations.
Business Combinations
Business Combinations
Business combinations are accounted for using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations, and are included in our consolidated financial statements from their respective acquisition dates. Assets acquired and liabilities assumed, if any, are measured at fair value on the acquisition date using the appropriate valuation method. Goodwill generated from acquisitions is recognized if the fair value of the purchase consideration transferred, or the fair value of the acquirer’s interest in the acquiree if no consideration is transferred, and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. In determining the fair value of identifiable assets, we use various valuation techniques which require us to make estimates and assumptions surrounding projected revenues and costs, future growth, and discount rates.
Goodwill
Goodwill
Goodwill represents the excess of the fair value of the purchase consideration transferred, or the fair value of the acquirer’s interest in the acquiree if no consideration is transferred, and any noncontrolling interests over the net fair value of the identifiable assets acquired and the liabilities assumed in business combinations. Goodwill is not amortized but is subject to an annual impairment test. We perform our annual goodwill impairment assessment on the first day of the fourth quarter. Tests are performed more frequently if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Goodwill is recorded in other assets in the consolidated balance sheet.
Other Intangible Assets
Other Intangible Assets
Other intangible assets include finite-lived intangible assets, which mainly consist of customer relationships, reacquired rights, and backlog. These assets are amortized over their estimated useful lives and are tested for impairment using a similar methodology to our property and equipment, as described below. Other intangible assets are recorded in other assets in the consolidated balance sheets.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets
Long-lived assets are reviewed for impairment annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparing the carrying amount of an asset to the future undiscounted cash flows that the asset is expected to generate. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Impairments of long-lived assets during the years ended December 31, 2023, 2022, and 2021 were not material.
Leases
Leases
The Company determines if an arrangement is a lease at inception. An arrangement is or contains a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If a lease is identified, classification is determined at lease commencement. Operating lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The Company’s leases do not provide an implicit interest rate and therefore the Company estimates its incremental borrowing rate to discount lease payments. The incremental borrowing rate reflects the interest rate that the Company would have to pay to borrow on a collateralized basis an amount equal to the lease payments in a similar economic environment over a similar term. Operating lease right-of-use (“ROU”) assets are based on the corresponding lease liability adjusted for any lease payments made at or before commencement, initial direct costs, and lease incentives. Renewals or early terminations are not accounted for unless the Company is reasonably certain to exercise these options. Operating lease expense is recognized and the ROU asset is amortized on a straight-line basis over the lease term.
The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. For short-term leases, defined as leases with a term of twelve months or less, the Company elected the practical expedient to not recognize an associated lease liability and ROU asset. Lease payments for short-term leases are expensed on a straight-line basis over the lease term.
Operating leases are included in operating lease right-of-use assets, operating lease liabilities, and operating lease liabilities, non-current on the Company’s consolidated balance sheets. Finance leases are not material.
Fair Value Measurement
Fair Value Measurement
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for that asset or liability in an orderly transaction between market participants on the measurement date.
The Company measures fair value based on a three-level hierarchy of inputs, maximizing the use of observable inputs, where available, and minimizing the use of unobservable inputs when measuring fair value. A financial instrument’s level within the three-level hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three-level hierarchy of inputs is as follows:
Level 1: Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;
Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on the Company’s own assumptions about current market conditions and require significant management judgment or estimation.
Financial instruments consist of money market funds and certificates of deposit included in cash equivalents and restricted cash, accounts receivable, marketable securities, other assets accounted for at fair value, accounts payable, and accrued liabilities. Money market funds, certificates of deposit, and marketable securities are stated at fair value on a recurring basis. Accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date.
Revenue Recognition
Revenue Recognition
The Company generates revenue from the sale of subscriptions to access its software platforms in the Company’s hosted environment, along with ongoing operations and maintenance (“O&M”) services (“Palantir Cloud”); software licenses, primarily term licenses in the customers’ environments, with ongoing O&M services (“On-Premises Software”); and professional services.
In accordance with ASC 606, Revenue from Contracts with Customers, the Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company applies the following five-step revenue recognition model in accounting for its revenue arrangements:
•Identification of the contract(s) with the customer, including whether collectability of the consideration is probable by considering the customers’ ability and intention to pay;
•Identification of the performance obligations in the contract;
•Determination of the transaction price;
•Allocation of the transaction price to the performance obligations in the contract; and
•Recognition of revenue when, or as, the Company satisfies a performance obligation.
Additionally, the pricing of the Company’s contracts is generally fixed; however, it is possible for contracts to include variable consideration, which can be based on subjective or objective criteria. The Company includes the estimated amount of variable consideration that it expects to receive to the extent it is probable that a significant revenue reversal will not occur.
Each of the Company’s significant performance obligations and the Company’s application of ASC 606 to its revenue arrangements is discussed in further detail below.
Palantir Cloud
The Company’s Palantir Cloud subscriptions grant customers the right to access the software functionality in a hosted environment controlled by Palantir and are sold together with stand-ready O&M services, as further described below. The Company agrees to provide continuous access to its hosted software platforms throughout the contract term. Revenue associated with Palantir Cloud subscriptions is generally recognized over the contract term on a ratable basis, which is consistent with the transfer of control of the Palantir Cloud subscription to the customer.
On-Premises Software
Sales of the Company’s software licenses, primarily term licenses, grant customers the right to use functional intellectual property, either on their internal hardware infrastructure or on their own cloud instance, over the contractual term and are also sold together with stand-ready O&M services. The O&M services include critical updates, support, and maintenance services required to operate the software and, as such, are necessary for the software to maintain its intended utility over the contractual term. Because of this requirement, the Company has concluded that the software licenses and O&M services, which together the Company refers to as On-Premises Software, are highly interdependent and interrelated and represent a single distinct performance obligation within the context of the contract. Revenue is generally recognized over the contract term on a ratable basis.
Professional Services
The Company’s professional services support the customers’ use of the software platforms and include, as needed, on-demand user support, user-interface configuration, training, and ongoing ontology and data modeling support. Professional services contracts typically include the provision of on-demand professional services for the duration of the contractual term. These services are typically coterminous with a Palantir Cloud subscription or the On-Premises Software. Professional services are on-demand, whereby the Company performs services throughout the contract period; therefore, the revenue is recognized over the contractual term.
Contract Liabilities
The timing of customer billings and payments relative to the start of the service period varies from contract to contract; however, the Company bills many of its customers in advance of the provision of services under its contracts, resulting in contract liabilities consisting of either deferred revenue or customer deposits (“contract liabilities”). Deferred revenue represents billings under noncancelable contracts before the related product or service is transferred to the customer. Customer deposits consist of amounts billed and/or paid in advance of the start of the contractual term or for anticipated revenue generating activities for the portion of a contract term that is subject to cancellation by its customers. Many of the Company’s arrangements include terms that allow the customer to terminate the contract for convenience and receive a pro-rata refund of the amount of the customer deposit for the period of time remaining in the contract term after the applicable termination notice period expires. In these arrangements, the Company concluded there are no enforceable rights and obligations after such notice period and therefore the consideration received or due from the customer that is subject to termination for convenience is recorded as customer deposits.
The payment terms and conditions vary by contract; however, the Company’s terms generally require payment within 30 to 60 days from the invoice date. In instances where the timing of revenue recognition differs from the timing of payment, the Company elected to apply the practical expedient in accordance with ASC 606 to not adjust contract consideration for the
effects of a significant financing component as the Company expects, at contract inception, that the period between when promised goods and services are transferred to the customer and when the customer pays for those goods and services will be one year or less. As such, the Company determined its contracts do not generally contain a significant financing component.
Areas of Judgment and Estimation
The Company’s contracts with customers can include multiple promises to transfer goods or services to the customer. Determining whether promises are distinct performance obligations that should be accounted for separately – or not distinct within the context of the contract and, thus, accounted for together – requires significant judgment. The Company concluded that the promise to provide a software license is highly interdependent and interrelated with the promise to provide O&M services and such promises are not distinct within the context of its contracts and are accounted for as a single performance obligation as the Company’s On-Premises Software.
Significant estimates and assumptions are used in the identification of performance obligations in customer contracts and collectability of contract consideration, including accounts receivable. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect our financial position and results of operations.
Costs to Obtain and Fulfill Contracts
Incremental costs of obtaining a contract include only those costs that are directly related to the acquisition of contracts, including sales commissions, and that would not have been incurred if the contract had not been obtained. The Company recognizes a contract cost asset for the incremental costs of obtaining a contract with a customer if it is expected that the economic benefit and amortization period will be longer than one year. Costs to obtain contracts were not material in the periods presented.
The Company recognizes an asset for the costs to fulfill a contract with a customer if the costs are specifically identifiable, generate or enhance resources used to satisfy future performance obligations, and are expected to be recovered. Costs to fulfill contracts were not material in the periods presented.
Software Development Costs
Software Development Costs
The Company evaluates capitalization of certain software development costs subsequent to the establishment of technological feasibility. Based on the Company’s product development process and substantial development risks, technological feasibility is generally established for the Company’s products when they are made available for general release. Accordingly, most costs are charged to research and development expense in the period incurred.
Cost of Revenue
Cost of Revenue
Cost of revenue primarily includes salaries, stock-based compensation expense, and benefits for personnel involved in performing O&M and professional services, as well as field service representatives, third-party cloud hosting services, travel costs, allocated overhead, and other direct costs.
Sales and Marketing Costs
Sales and Marketing Costs
Sales and marketing costs primarily include salaries, stock-based compensation expense, commissions, and benefits for the sales force and personnel involved in sales functions, executing on pilots, including bootcamps, and performing other brand building and customer growth activities, as well as third-party cloud hosting services for pilots, marketing and sales event-related costs, travel costs, and allocated overhead. The Company generally charges all such costs to sales and marketing expense in the period incurred. Advertising costs are expensed as incurred and included in sales and marketing expense within the consolidated statements of operations. Advertising expense totaled $21.4 million, $38.6 million, and $26.3 million for the years ended December 31, 2023, 2022, and 2021, respectively.
Research and Development Costs
Research and Development Costs
Research and development costs primarily include salaries, stock-based compensation expense, and benefits for personnel involved in performing the activities to develop and refine the Company’s platforms and products, as well as third-party cloud hosting services and other IT related costs, travel costs, and allocated overhead. Research and development costs are expensed as incurred.
Commitments and Contingencies
Commitments and Contingencies
Liabilities for loss contingencies arising from claims, disputes, legal proceedings, fines and penalties, and other sources are recorded when it is probable that a liability has been or will be incurred and the amount of the liability can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred. Recoveries of such legal costs from insurance policies are recorded as an offset to legal expenses in the period they are received.
Stock-Based Compensation
Stock-Based Compensation
The Company accounts for stock-based compensation expense in accordance with the fair value recognition and measurement provisions of GAAP, which require compensation cost for the grant-date fair value of stock-based awards to be recognized over the requisite service period. The Company determines the fair value of stock-based awards granted or modified on the grant date or modification date using appropriate valuation techniques. The Company recognizes forfeitures as they occur.
Service-Based Vesting
The Company grants RSUs and stock option awards that vest based upon the satisfaction of only a service condition. For RSUs, the Company determines the grant-date fair value of the RSUs as the fair value of the Company’s common stock on the grant date. The Company records stock-based compensation expense for stock options and RSUs that vest based upon the satisfaction of only a service condition on a straight-line basis over the requisite service period, which is generally one to four years. For stock option awards, the Company uses the Black-Scholes option pricing model to determine the fair value of the stock options granted. The Black-Scholes option pricing model requires the input of highly subjective assumptions, including the expected term of the option, the expected volatility of the price of the common stock, risk-free interest rates, and the expected dividend yield of the common stock. The assumptions used to determine the fair value of the option awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.
Performance-Based Vesting
The Company also grants awards, including RSUs, that vest upon the satisfaction of both a service condition and a performance condition. The Company determines the grant-date fair value of RSUs with both a service-based vesting condition and a performance-based vesting condition as the fair value of the Company’s common stock on the grant date and records stock-based compensation expense using the accelerated attribution method over the service period. The performance-based vesting condition for the RSUs granted prior to September 30, 2020, the date the Company completed a direct listing of its Class A common stock on the New York Stock Exchange (the “Direct Listing”) was satisfied upon the occurrence of the Company’s Direct Listing. For performance-based RSUs granted after the Direct Listing (“P-RSUs”), the Company recognizes expense from the number of P-RSUs expected to vest, determined based on the level of achievement against certain performance conditions, over the requisite service period when it is probable that the performance condition will be achieved. The probability of achievement is assessed periodically to determine whether the performance metric continues to be probable. When there is a change in the assessment of the probability of achievement, any cumulative effect of the change is recognized in the period of the change and any remaining expense of the related awards is amortized over the remaining service period.
Employee Benefit Plan
Employee Benefit Plan
The Company sponsors a 401(k) tax-deferred savings plan for all employees who meet certain eligibility requirements. Participants may contribute, on a pretax and post-tax basis, a percentage of their qualifying annual compensation, but not to exceed a maximum contribution amount pursuant to Section 401(k) of the Internal Revenue Code. The Company may make additional matching contributions on behalf of the participants. The Company did not make matching contributions for the years ended December 31, 2023, 2022, and 2021.
Income Taxes
Income Taxes
The Company estimates its current tax expense together with assessing temporary differences resulting from differing treatment of items not currently deductible for tax purposes. These differences result in deferred tax assets and liabilities on the Company’s consolidated balance sheets, which are estimated based upon the difference between the financial statement and tax bases of assets and liabilities using the enacted tax rates that will be in effect when these differences reverse. In general, deferred tax assets represent future tax benefits to be received when certain expenses previously recognized in the Company’s consolidated statements of operations become deductible expenses under applicable income tax laws or loss or credit carryforwards are utilized. Accordingly, the realization of the Company’s deferred tax assets is dependent on future taxable income against which these deductions, losses, and credits can be utilized.
The Company evaluates the realizability of its deferred tax assets and recognizes a valuation allowance when it is more likely than not that a future benefit on such deferred tax assets will not be realized. The Company considers all evidence, both positive and negative, in determining any required valuation allowance and evaluates the need for a valuation allowance on a regular basis. The Company performs an assessment of both positive and negative evidence when determining whether it is more likely
than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction by jurisdiction basis. The Company reviews the recognition of deferred tax assets on a regular basis to determine if realization of such assets is more likely than not. A valuation allowance is provided when it is more likely than not that such assets will not be realized. If certain factors change and the Company determines that the deferred tax assets are realizable at a more-likely-than not level, it will adjust the valuation allowance in the period the determination is made. Changes in the valuation allowance, when recorded, would be included in the Company’s consolidated statements of operations. Management’s judgment is required in determining the Company’s valuation allowance recorded against its net deferred tax assets.
The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. The Company recognizes interest and penalties related to uncertain tax positions in its provision for income taxes. The Company is subject to the Global Intangible Low Taxed Income (“GILTI”) tax in the U.S. and has elected to treat taxes on future GILTI inclusions as current period expense if and when incurred.
Net Earnings (Loss) Per Share Attributable to Common Stockholders
Net Earnings (Loss) Per Share Attributable to Common Stockholders
The Company computes net earnings (loss) per share attributable to its common stockholders using the two-class method required for participating securities, which determines net earnings (loss) per common share for each class of common stock and participating securities according to dividends declared or accumulated and participation rights in distributed and undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed.
The rights, including the liquidation and dividend rights, of the holders of Class A, Class B, and Class F common stock (collectively, the “common stock”) are identical, except with respect to voting and conversion. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting net earnings (loss) per share will, therefore, be the same for all classes of common stock on an individual or combined basis. As such, the Company has presented the net income (loss) attributed to its common stock on a combined basis.
Noncontrolling Interests
Noncontrolling Interests
A noncontrolling interest represents the proportionate equity interest in a subsidiary that is not attributable, either directly or indirectly, to the Company and is reported as equity of the Company, separate from the Company’s controlling interest. Revenues, expenses, gains, losses, net income (loss), and other comprehensive income (loss) are reported in the consolidated financial statements at the consolidated amounts, which include the amounts attributable to both the controlling and noncontrolling interest.
Foreign Currency
Foreign Currency
Generally, the functional currency of the Company’s international subsidiaries is the local currency of the country in which they operate. The Company translates the assets and liabilities of its non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each reporting period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recognized as a cumulative translation adjustment and included in accumulated other comprehensive income (loss).
For transactions that are not denominated in the local functional currency, the Company remeasures monetary assets and liabilities at exchange rates in effect at the end of each reporting period. Transaction gains and losses from the remeasurement are recognized in other income (expense), net within the consolidated statements of operations.
Recent Accounting Pronouncements Not Yet Adopted
Recent Accounting Pronouncements Not Yet Adopted
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires disclosure of incremental segment information on an annual and interim basis. This standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. The Company is currently evaluating the impacts of the new standard.
In December 2023, the FASB issued ASU 2023-09, Income Taxes – Improvements to Income Tax Disclosures, requiring enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impacts of the new standard.
v3.24.0.1
Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the amounts shown in the consolidated statements of cash flows (in thousands):
As of December 31,
202320222021
Cash and cash equivalents$831,047 $2,598,540 $2,290,674 
Restricted cash included in prepaid expenses and other current assets370 16,244 36,628 
Restricted cash included in other assets18,690 12,551 39,612 
Total cash, cash equivalents, and restricted cash$850,107 $2,627,335 $2,366,914 
v3.24.0.1
Investments and Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Summary Of Assets and Liabilities that are Measured at Fair Value on a Recurring and Nonrecurring Basis
The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation (in thousands):
As of December 31, 2023
TotalLevel 1Level 2Level 3
Assets:
Cash and cash equivalents:
Money market funds$576,565 $576,565 $— $— 
U.S. treasury securities10,079 — 10,079 — 
Certificates of deposit938 — 938 — 
Prepaid expenses and other current assets and other assets:
Certificates of deposit4,777 — 4,777 — 
Marketable securities:
U.S. treasury securities2,824,861 — 2,824,861 — 
Publicly-traded equity securities18,271 18,271 — — 
Total$3,435,491 $594,836 $2,840,655 $— 
As of December 31, 2022
TotalLevel 1Level 2Level 3
Assets:
Cash and cash equivalents:
Money market funds$1,149,302 $1,149,302 $— $— 
Certificates of deposit6,791 — 6,791 — 
Prepaid expenses and other current assets and other assets:
Certificates of deposit18,707 — 18,707 — 
Marketable securities:
Publicly-traded equity securities35,135 35,135 — — 
Total$1,209,935 $1,184,437 $25,498 $— 
Debt Securities, Available-for-Sale
As of December 31, 2023, available-for-sale debt securities consisted of the following (in thousands):
As of December 31, 2023
Amortized CostUnrealized GainsUnrealized LossesFair Value
U.S. treasury securities$2,831,505 $4,520 $(1,085)$2,834,940 
Total debt securities$2,831,505 $4,520 $(1,085)$2,834,940 
Included in cash and cash equivalents$10,078 $1 $— $10,079 
Included in marketable securities$2,821,427 $4,519 $(1,085)$2,824,861 
v3.24.0.1
Balance Sheet Components (Tables)
 12 Months Ended
Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]  
Schedule of Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
As of December 31,
20232022
Leasehold improvements$83,139 $80,378 
Computer equipment, software, and other50,844 52,688 
Furniture and fixtures13,834 13,010 
Construction in progress2,099 5,506 
Total property and equipment, gross149,916 151,582 
Less: accumulated depreciation and amortization(102,158)(82,412)
Total property and equipment, net$47,758 $69,170 
Schedule of Accrued Liabilities
Accrued liabilities consisted of the following (in thousands):
As of December 31,
20232022
Accrued payroll and related expenses$83,094 $43,495 
Accrued taxes47,257 41,326 
Accrued other liabilities92,640 87,894 
Total accrued liabilities$222,991 $172,715 
v3.24.0.1
Leases (Tables)
 12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Supplemental Balance Sheet Information Related To Lease Liabilities and Components of Lease Expense
Supplemental balance sheet information related to lease liabilities at December 31, 2023 and 2022 was as follows (in thousands):
As of December 31,
Lease-Related Assets and LiabilitiesFinancial Statement Line Items20232022
Right-of-use assets:
Operating leasesOperating lease right-of-use assets$182,863 $200,240 
Total right-of-use assets$182,863 $200,240 
Lease liabilities:
Operating leasesOperating lease liabilities$54,176 $45,099 
Operating lease liabilities, noncurrent175,216 204,305 
Total lease liabilities$229,392 $249,404 
The components of lease expense included in the Company's consolidated statements of operations include (in thousands):
Years Ended December 31,
20232022
Operating lease expense$61,972 $55,483 
Short-term lease expense4,949 4,956 
Variable lease expense4,772 5,309 
Sublease income(18,905)(13,011)
Total lease expense, net$52,788 $52,737 
The following table sets forth the supplemental information related to the Company's operating leases for the years ended December 31, 2023 and 2022 (in thousands):
Years Ended December 31,
20232022
Cash paid for operating lease liabilities$63,374 $53,772 
Lease liabilities arising from obtaining right-of-use assets
$28,112 $28,169 
Maturities of Operating Lease Liabilities
Maturities of operating lease liabilities as of December 31, 2023 were as follows (in thousands):
As of December 31, 2023
Operating Lease CommitmentsLess: Sublease IncomeNet Lease Commitments
Year ended December 31,
2024$67,420 $16,593 $50,827 
202557,053 14,357 42,696 
202640,068 13,748 26,320 
202728,278 14,423 13,855 
202821,816 12,470 9,346 
Thereafter62,116 30,761 31,355 
Total undiscounted liabilities276,751 102,352 174,399 
Less: Imputed interest(47,359)— (47,359)
Total operating lease liabilities$229,392 $102,352 $127,040 
v3.24.0.1
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2023
Stockholders' Equity Note [Abstract]  
Summary of Total Authorized, Issued, And Outstanding Shares
The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands):
As of December 31, 2023As of December 31, 2022
AuthorizedIssued and OutstandingAuthorizedIssued and Outstanding
Class A Common Stock20,000,000 2,096,982 20,000,000 1,995,414 
Class B Common Stock2,700,000 102,141 2,700,000 102,656 
Class F Common Stock1,005 1,005 1,005 1,005 
Total22,701,005 2,200,128 22,701,005 2,099,075 
v3.24.0.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity
The following table summarizes stock option activity for the year ended December 31, 2023 (in thousands, except per share amounts):
Options Outstanding
Weighted-Average Exercise Price Per Share
Weighted-Average
Remaining Contractual Life (years)
Aggregate Intrinsic Value
Balance as of December 31, 2022326,913 $8.05 8.33$272,603 
Options exercised(46,079)4.74 
Options canceled and forfeited(2,364)5.39 
Balance as of December 31, 2023278,470 $8.62 7.64$2,381,172 
Options vested and exercisable as of December 31, 2023160,877 $6.66 6.93$1,691,404 
Summary of RSU Activity
The following table summarizes the RSU and P-RSU activity for the year ended December 31, 2023 (in thousands, except per share amounts):
RSUsP-RSUs
Units OutstandingWeighted Average Grant Date Fair Value per ShareUnits OutstandingWeighted Average Grant Date Fair Value per Share
Unvested and outstanding as of December 31, 2022126,426 $10.07 — $— 
Granted19,484 11.77 1,976 15.39 
Vested(54,974)9.57 — — 
Canceled(8,674)11.08 — — 
Unvested and outstanding as of December 31, 202382,262 $10.71 1,976 $15.39 
Summary of Stock-Based Compensation Expense
Total stock-based compensation expense was as follows (in thousands):
Years Ended December 31,
202320222021
Cost of revenue$35,995 $44,061 $68,546 
Sales and marketing160,645 196,301 242,910 
Research and development98,064 93,871 150,298 
General and administrative181,199 230,565 316,461 
Total stock-based compensation expense$475,903 $564,798 $778,215 
v3.24.0.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Summary of Loss Before Provision for (benefit from) Income Taxes
Income (loss) before provision for income taxes consisted of the following (in thousands):
Years Ended December 31,
202320222021
United States$174,637 $(402,834)$(514,200)
Foreign62,454 41,807 25,706 
Income (loss) before provision for income taxes$237,091 $(361,027)$(488,494)
Summary of Provision for (benefit from) Income Taxes
Provision for income taxes consisted of the following (in thousands):
Years Ended December 31,
202320222021
Current:
Federal$— $— $— 
State2,333 765 (88)
Foreign22,189 9,476 (11,343)
Total current provision24,522 10,241 (11,431)
Deferred:
Federal— — (111)
State— — — 
Foreign(4,806)(174)43,427 
Total deferred provision(4,806)(174)43,316 
Total provision for income taxes$19,716 $10,067 $31,885 
Summary of Reconciliation of Effective Income Tax Rate
A reconciliation of the expected tax provision at the statutory federal income tax rate to the Company’s recorded tax provision consisted of the following (in thousands):
Years Ended December 31,
202320222021
Expected tax (benefit) at U.S. federal statutory rate$49,789 $(75,592)$(102,584)
State income taxes - net of federal benefit2,309 766 (88)
Foreign tax rate differential859 832 870 
Research and development tax credits(45,667)(34,546)(94,591)
Stock-based compensation(79,128)1,374 (817,839)
Non-deductible officers’ compensation
34,479 40,629 428,682 
Change in valuation allowance35,070 49,833 616,572 
Base Erosion Anti-Abuse Tax and related elections14,700 25,200 — 
Taxes withheld at source4,378 — — 
Non-deductible expenses3,610 — — 
Other(683)1,571 863 
Total provision for income taxes$19,716 $10,067 $31,885 
Summary of Significant Deferred Tax Assets and Liabilities Significant deferred tax assets and liabilities consisted of the following (in thousands):
As of December 31,
20232022
Net operating loss carryforwards$1,317,684 $1,436,957 
Capitalized research and experimental expenses214,848 70,839 
Reserves and accruals99,105 76,905 
Tax credit carryforwards277,060 226,565 
Stock-based compensation139,419 203,735 
Lease liabilities53,902 58,056 
Depreciation and amortization14,413 29,665 
Capitalized facilitative expenses28,906 — 
Gross deferred tax assets2,145,337 2,102,722 
Outside basis difference— (6,512)
Acquisition related intangibles(8,428)(10,225)
Right-of-use assets(42,721)(46,295)
Total net deferred tax assets before valuation allowance2,094,188 2,039,690 
Valuation allowance(2,102,251)(2,051,655)
Net deferred tax assets (liabilities)$(8,063)$(11,965)
Summary of Reconciliation of the Gross Unrecognized Tax Benefits
A reconciliation of the gross unrecognized tax benefits consists of the following (in thousands):
Years Ended December 31,
202320222021
Unrecognized tax benefit beginning of year$81,904 $65,070 $75,557 
Increases in current year tax positions14,346 5,733 19,638 
Increases in prior year tax positions15,766 11,497 967 
Decreases in prior year tax positions— (36)(30,895)
Decreases in prior year tax positions due to settlements— (360)(197)
Decreases in prior year tax positions due to lapse of statute of limitations— — — 
Unrecognized tax benefit end of year$112,016 $81,904 $65,070 
v3.24.0.1
Net Earnings (Loss) Per Share Attributable to Common Stockholders (Tables)
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Summary of Calculation of Basic and Diluted Net Loss Per Share
The following table presents the calculation of basic and diluted net earnings (loss) per share attributable to common stockholders (in thousands, except share and per share amounts):
As of December 31,
202320222021
Numerator
Net income (loss) attributable to common stockholders for diluted net earnings (loss) per share$209,825 $(373,705)$(520,379)
Denominator
Weighted-average shares used in computing net earnings (loss) per share:
Basic2,147,446 2,063,793 1,923,617 
Effect of dilutive shares150,481 — — 
Diluted2,297,927 2,063,793 1,923,617 
Net earnings (loss) per share
Net earnings (loss) per share attributable to common stockholders:
Basic$0.10 $(0.18)$(0.27)
Diluted$0.09 $(0.18)$(0.27)
Summary of Antidilutive Securities
The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net earnings (loss) per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands):
As of December 31,
202320222021
Options and SARs issued and outstanding162,000 326,913 349,977 
RSUs and P-RSUs outstanding13,245 126,426 153,749 
Warrants to purchase common stock— 13,042 13,042 
Total175,245 466,381 516,768 
v3.24.0.1
Segment and Geographic Information (Tables)
 12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Summary of Financial Information for Each Reportable Segment
Financial information for each reportable segment was as follows (in thousands):
Years Ended December 31,
202320222021
Revenue:
Government$1,222,215 $1,071,776 $897,356 
Commercial1,002,797 834,095 644,533 
Total revenue$2,225,012 $1,905,871 $1,541,889 
Years Ended December 31,
202320222021
Amount%Amount%Amount%
Contribution:
Government$724,970 59 %$620,677 58 %$541,883 60 %
Commercial520,585 52 %414,496 50 %357,546 55 %
Total contribution$1,245,555 56 %$1,035,173 54 %$899,429 58 %
Summary of Reconciliation of Segment Financial Information to Loss from Operations
The reconciliation of contribution to income (loss) from operations is as follows (in thousands):
Years Ended December 31,
202320222021
Income (loss) from operations
$119,966 $(161,201)$(411,046)
Research and development expenses (1)
306,560 265,808 237,189 
General and administrative expenses (1)
343,126 365,768 295,071 
Total stock-based compensation expense475,903 564,798 778,215 
Total contribution$1,245,555 $1,035,173 $899,429 
—————
(1) Excludes stock-based compensation expense.
Summary of Revenue by Geography
Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages):
Years Ended December 31,
202320222021
Amount%Amount%Amount%
Revenue:
United States$1,378,247 62 %$1,161,416 61 %$879,156 57 %
United Kingdom235,257 11 %220,942 12 %173,362 11 %
Rest of world (1)
611,508 27 %523,513 27 %489,371 32 %
Total revenue$2,225,012 100 %$1,905,871 100 %$1,541,889 100 %
—————
(1) No other country represented 10% or more of total revenue for the years ended December 31, 2023, 2022, or 2021.
Summary of Property and Equipment, Net by Geography
Property and equipment, net is attributed to the Company’s office locations as follows (in thousands, except percentages):
As of December 31,
20232022
Amount%Amount%
Property and equipment, net:
United States$28,825 60 %$46,599 67 %
Japan11,440 24 %13,318 19 %
United Kingdom5,851 12 %6,746 10 %
Rest of world1,642 4 %2,507 4 %
Total property and equipment, net$47,758 100 %$69,170 100 %
v3.24.0.1
Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets
Intangible assets subject to amortization that are not fully amortized are as follows (in thousands):
Weighted average useful lifeAs of December 31, 2023As of December 31, 2022
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Customer relationships3.83$10,400 $(2,427)$7,973 $10,400 $(347)$10,053 
Reacquired rights5.8317,618 (2,936)14,682 17,619 (420)17,199 
Backlog0.836,700 (3,908)2,792 6,700 (558)6,142 
Other0.274,225 (3,770)455 5,717 (3,572)2,145 
Total intangible assets$38,943 $(13,041)$25,902 $40,436 $(4,897)$35,539 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
As of December 31, 2023, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows (in thousands):
Year ended December 31,Amount
2024$7,844 
20254,597 
20264,597 
20274,250 
20282,517 
Thereafter2,097 
Total$25,902 
v3.24.0.1
Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash and Cash Equivalents [Line Items]        
Cash and cash equivalents $ 831,047 $ 2,598,540 $ 2,290,674  
Total cash, cash equivalents, and restricted cash 850,107 2,627,335 2,366,914 $ 2,128,146
Prepaid Expenses and Other Current Assets        
Cash and Cash Equivalents [Line Items]        
Restricted cash 370 16,244 36,628  
Other Current Assets        
Cash and Cash Equivalents [Line Items]        
Restricted cash $ 18,690 $ 12,551 $ 39,612  
v3.24.0.1
Significant Accounting Policies - Additional Information (Detail)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
USD ($)
segment
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Accounting Policies [Line Items]      
Number of operating segments | segment 2    
Allowance for credit losses $ 10,500 $ 10,100  
Accounts receivable, net $ 364,784 258,346  
Useful lives (in years) 3 years    
Advertising expense $ 21,400 $ 38,600 $ 26,300
Minimum      
Accounting Policies [Line Items]      
Share based payment award vesting period 4 years    
Maximum      
Accounting Policies [Line Items]      
Share based payment award vesting period 1 year    
Leasehold improvements      
Accounting Policies [Line Items]      
Useful lives (in years) 5 years    
Customer I | Accounts Receivable Benchmark | Customer Concentration Risk      
Accounting Policies [Line Items]      
Concentration risk (in percent) 15.00%    
v3.24.0.1
Contract Liabilities and Remaining Performance Obligations - Additional information (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Contract with customer, liability $ 486.3 $ 339.2
Revenue recognized from contract liability balances 329.4 $ 384.3
Remaining performance obligation $ 1,200.0  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Remaining performance obligation (as percent) 52.00%  
Expected timing of satisfaction (in months) 12 months  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Remaining performance obligation (as percent) 37.00%  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | Minimum    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Expected timing of satisfaction (in months) 13 months  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | Maximum    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Expected timing of satisfaction (in months) 36 months  
v3.24.0.1
Investments and Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Marketable securities:      
Debt securities $ 2,834,940,000 $ 0  
Total 3,435,491,000 1,209,935,000  
Revenues 2,225,012,000 1,905,871,000 $ 1,541,889,000
Level 1      
Marketable securities:      
Total 594,836,000 1,184,437,000  
Level 2      
Marketable securities:      
Total 2,840,655,000 25,498,000  
Level 3      
Marketable securities:      
Total 0 0  
U.S. treasury securities      
Marketable securities:      
Debt securities 2,834,940,000    
Cash and Cash Equivalents | Money market funds      
Cash and cash equivalents:      
Cash and cash equivalents 576,565,000 1,149,302,000  
Cash and Cash Equivalents | Money market funds | Level 1      
Cash and cash equivalents:      
Cash and cash equivalents 576,565,000 1,149,302,000  
Cash and Cash Equivalents | Money market funds | Level 2      
Cash and cash equivalents:      
Cash and cash equivalents 0 0  
Cash and Cash Equivalents | Money market funds | Level 3      
Cash and cash equivalents:      
Cash and cash equivalents 0 0  
Cash and Cash Equivalents | U.S. treasury securities      
Cash and cash equivalents:      
Cash and cash equivalents 10,079,000    
Marketable securities:      
Debt securities 10,079,000    
Cash and Cash Equivalents | U.S. treasury securities | Level 1      
Cash and cash equivalents:      
Cash and cash equivalents 0    
Cash and Cash Equivalents | U.S. treasury securities | Level 2      
Cash and cash equivalents:      
Cash and cash equivalents 10,079,000    
Cash and Cash Equivalents | U.S. treasury securities | Level 3      
Cash and cash equivalents:      
Cash and cash equivalents 0    
Cash and Cash Equivalents | Certificates of deposit      
Cash and cash equivalents:      
Cash and cash equivalents 938,000 6,791,000  
Cash and Cash Equivalents | Certificates of deposit | Level 1      
Cash and cash equivalents:      
Cash and cash equivalents 0 0  
Cash and Cash Equivalents | Certificates of deposit | Level 2      
Cash and cash equivalents:      
Cash and cash equivalents 938,000 6,791,000  
Cash and Cash Equivalents | Certificates of deposit | Level 3      
Cash and cash equivalents:      
Cash and cash equivalents 0 0  
Prepaid Expenses and Other Current Assets and Other Assets | Certificates of deposit      
Prepaid expenses and other current assets and other assets:      
Certificates of deposit 4,777,000 18,707,000  
Prepaid Expenses and Other Current Assets and Other Assets | Certificates of deposit | Level 1      
Prepaid expenses and other current assets and other assets:      
Certificates of deposit 0 0  
Prepaid Expenses and Other Current Assets and Other Assets | Certificates of deposit | Level 2      
Prepaid expenses and other current assets and other assets:      
Certificates of deposit 4,777,000 18,707,000  
Prepaid Expenses and Other Current Assets and Other Assets | Certificates of deposit | Level 3      
Prepaid expenses and other current assets and other assets:      
Certificates of deposit 0 0  
Marketable Securities | U.S. treasury securities      
Marketable securities:      
Debt securities 2,824,861,000    
Marketable Securities | U.S. treasury securities | Level 1      
Marketable securities:      
Debt securities 0    
Marketable Securities | U.S. treasury securities | Level 2      
Marketable securities:      
Debt securities 2,824,861,000    
Marketable Securities | U.S. treasury securities | Level 3      
Marketable securities:      
Debt securities 0    
Marketable Securities | U.S. treasury securities      
Marketable securities:      
U.S. treasury securities 18,271,000 35,135,000  
Marketable Securities | U.S. treasury securities | Level 1      
Marketable securities:      
U.S. treasury securities 18,271,000 35,135,000  
Marketable Securities | U.S. treasury securities | Level 2      
Marketable securities:      
U.S. treasury securities 0 0  
Marketable Securities | U.S. treasury securities | Level 3      
Marketable securities:      
U.S. treasury securities $ 0 $ 0  
v3.24.0.1
Investments and Fair Value Measurements - Available-For-Sale Debt Securities (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Debt Securities, Available-for-Sale [Line Items]    
Amortized Cost $ 2,831,505,000  
Unrealized Gains 4,520,000  
Unrealized Losses (1,085,000)  
Fair Value 2,834,940,000 $ 0
U.S. treasury securities    
Debt Securities, Available-for-Sale [Line Items]    
Amortized Cost 2,831,505,000  
Unrealized Gains 4,520,000  
Unrealized Losses (1,085,000)  
Fair Value 2,834,940,000  
U.S. treasury securities | Cash and Cash Equivalents    
Debt Securities, Available-for-Sale [Line Items]    
Amortized Cost 10,078,000  
Unrealized Gains 1,000  
Unrealized Losses 0  
Fair Value 10,079,000  
U.S. treasury securities | Current Marketable Securities    
Debt Securities, Available-for-Sale [Line Items]    
Amortized Cost 2,821,427,000  
Unrealized Gains 4,519,000  
Unrealized Losses (1,085,000)  
Fair Value $ 2,824,861,000  
v3.24.0.1
Investments and Fair Value Measurements - Additional Information (Detail)
 12 Months Ended 36 Months Ended
Dec. 31, 2023
USD ($)
security
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
oz
Dec. 31, 2023
USD ($)
security
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Proceeds from sale of available-for-sale securities $ 694,600,000      
Credit or non-credit losses related to debt securities 0      
Available-for-sale debt securities in unrealized loss position $ 236,000,000     $ 236,000,000
Number of securities in an unrealized loss position for greater than 12 months | security 0     0
Debt securities $ 2,834,940,000 $ 0   $ 2,834,940,000
Equity securities received as noncash consideration 41,700,000 6,800,000 $ 0  
Unrealized gain (loss) from equity securities   (159,000,000) (72,800,000)  
Realized loss from equity securities   113,100,000    
Realized gain (loss) for equity securities     0  
Privately-held equity securities without readily determinable fair value, amount 32,600,000 24,400,000   32,600,000
Revenues 2,225,012,000 1,905,871,000 1,541,889,000  
Investment in physical commodities     $ 50,900,000  
Weight of commodities purchased | oz     100  
Proceeds from sales of alternative investments 51,100,000      
Publicly-Traded Equity Securities Held        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Unrealized gain (loss) from equity securities (4,500,000) (197,300,000) $ (72,800,000)  
Investment Agreement        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Aggregate purchase price 0 $ 124,500,000   0
Commercial Contract | Investment Agreement        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Maximum contract value 376,500,000     376,500,000
Revenues 87,300,000     253,900,000
Commercial Contract | Investment Agreement | Maximum        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contractual option amounts $ 40,400,000     $ 40,400,000
Subscription contract term 7 years      
Commercial Contract | Investment Agreement | Minimum        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Subscription contract term 2 years      
v3.24.0.1
Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Balance Sheet Related Disclosures [Line Items]    
Total property and equipment, gross $ 149,916 $ 151,582
Less: accumulated depreciation and amortization (102,158) (82,412)
Total property and equipment, net 47,758 69,170
Leasehold improvements    
Balance Sheet Related Disclosures [Line Items]    
Total property and equipment, gross 83,139 80,378
Computer equipment, software, and other    
Balance Sheet Related Disclosures [Line Items]    
Total property and equipment, gross 50,844 52,688
Furniture and fixtures    
Balance Sheet Related Disclosures [Line Items]    
Total property and equipment, gross 13,834 13,010
Construction in progress    
Balance Sheet Related Disclosures [Line Items]    
Total property and equipment, gross $ 2,099 $ 5,506
v3.24.0.1
Balance Sheet Components - Additional information (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Balance Sheet Related Disclosures [Abstract]      
Depreciation and amortization expense excluding the impact of foreign exchange fluctuations $ 23.7 $ 19.5 $ 12.8
v3.24.0.1
Balance Sheet Components - Schedule of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Balance Sheet Related Disclosures [Abstract]    
Accrued payroll and related expenses $ 83,094 $ 43,495
Accrued taxes 47,257 41,326
Accrued other liabilities 92,640 87,894
Total accrued liabilities $ 222,991 $ 172,715
v3.24.0.1
Debt - Additional Information (Detail) - 2014 Revolving Credit Facility - Line of Credit
 12 Months Ended
Dec. 31, 2023
USD ($)
Short-Term Debt [Line Items]  
Debt instrument maximum borrowing capacity $ 500,000,000
Revolving Credit Facility  
Short-Term Debt [Line Items]  
Debt instrument carrying amount 0
Line of credit minimum liquidity to be maintained $ 50,000,000
v3.24.0.1
Leases - Additional Information (Detail)
$ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
option
Dec. 31, 2022
Leases [Abstract]    
Number of options to extend leases | option 1  
Weighted average remaining lease term (in years) 6 years 7 years
Weighted average discount rate (in percent) 6.00% 6.00%
Leases not yet commenced | $ $ 0.0  
v3.24.0.1
Leases - Summary Balance Sheet Information Relating to Leases (Detail) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Lease-Related Assets and Liabilities    
Operating lease right-of-use assets $ 182,863 $ 200,240
Total right-of-use assets 182,863 200,240
Lease liabilities:    
Operating lease liabilities 54,176 45,099
Operating lease liabilities, noncurrent 175,216 204,305
Total operating lease liabilities $ 229,392 $ 249,404
v3.24.0.1
Leases - Summary of Operating Lease Cost (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Lease, Cost [Abstract]    
Operating lease expense $ 61,972 $ 55,483
Short-term lease expense 4,949 4,956
Variable lease expense 4,772 5,309
Sublease income (18,905) (13,011)
Total lease expense, net $ 52,788 $ 52,737
v3.24.0.1
Leases - Maturities of Operating Lease Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Operating Lease Commitments    
2024 $ 67,420  
2025 57,053  
2026 40,068  
2027 28,278  
2028 21,816  
Thereafter 62,116  
Total undiscounted liabilities 276,751  
Less: Imputed interest (47,359)  
Total operating lease liabilities 229,392 $ 249,404
Less: Sublease Income    
2024 16,593  
2025 14,357  
2026 13,748  
2027 14,423  
2028 12,470  
Thereafter 30,761  
Total undiscounted liabilities 102,352  
Less: Imputed interest 0  
Total operating lease liabilities 102,352  
Net Lease Commitments    
2024 50,827  
2025 42,696  
2026 26,320  
2027 13,855  
2028 9,346  
Thereafter 31,355  
Total undiscounted liabilities 174,399  
Less: Imputed interest (47,359)  
Total operating lease liabilities $ 127,040  
v3.24.0.1
Leases - Summary of Supplemental Cash Flow Information Related to Operating Leases (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Cash paid for operating lease liabilities $ 63,374 $ 53,772
Lease liabilities arising from obtaining right-of-use assets $ 28,112 $ 28,169
v3.24.0.1
Commitments and Contingencies - Additional Information (Detail) - Purchase Commitment Two - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2023
Purchase Commitment, Excluding Long-Term Commitment [Line Items]    
Minimum annual commitment $ 1,950.0  
Period for purchase price commitment (in years) 10 years  
Purchase commitment for current contract year   $ 40.7
Purchase commitment for year one $ 154.0  
v3.24.0.1
Stockholders' Equity - Additional Information (Detail)
 12 Months Ended
Dec. 31, 2023
USD ($)
vote
shares
Aug. 31, 2023
USD ($)
Class of Stock [Line Items]    
Minimum ownership threshold (in shares) | shares 100,000,000  
Dividends declared | $ $ 0  
Stock repurchase program, authorized amount | $   $ 1,000,000,000
Stock repurchased during period (in shares) | shares 0  
Class A Common Stock    
Class of Stock [Line Items]    
Voting rights | vote 1  
Class B Common Stock    
Class of Stock [Line Items]    
Voting rights | vote 10  
Common stock, convertible, conversion ratio 1  
Class F Common Stock    
Class of Stock [Line Items]    
Control of total voting power 50.00%  
v3.24.0.1
Stockholders' Equity - Summary of Total Authorized, Issued, And Outstanding Shares (Detail) - shares
Dec. 31, 2023
Dec. 31, 2022
Class of Stock [Line Items]    
Authorized 22,701,005,000 22,701,005,000
Issued 2,200,128,000 2,099,075,000
Outstanding 2,200,128,000 2,099,075,000
Class A Common Stock    
Class of Stock [Line Items]    
Authorized 20,000,000,000 20,000,000,000
Issued 2,096,982,000 1,995,414,000
Outstanding 2,096,982,000 1,995,414,000
Class B Common Stock    
Class of Stock [Line Items]    
Authorized 2,700,000,000 2,700,000,000
Issued 102,141,000 102,656,000
Outstanding 102,141,000 102,656,000
Class F Common Stock    
Class of Stock [Line Items]    
Authorized 1,005,000 1,005,000
Issued 1,005,000 1,005,000
Outstanding 1,005,000 1,005,000
v3.24.0.1
Stock-Based Compensation - Additional Information (Detail) - USD ($)
 1 Months Ended 12 Months Ended
Sep. 30, 2020
Aug. 30, 2020
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Options granted (in shares)     0 0 0
Options vested and exercisable (in years)     6 years 11 months 4 days    
Aggregate intrinsic value of options exercised     $ 476,800,000 $ 112,300,000 $ 3,800,000,000
Grant date fair value of stock options vested during period     131,000,000 170,800,000 189,500,000
Unrecognized share based compensation expense     $ 599,100,000    
Unrecognized share based compensation expense, period for recognition (in years)     7 years    
Tax benefits related to stock-based compensation expense     $ 0 0 0
Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share based payment award vesting period     4 years    
Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share based payment award vesting period     1 year    
Restricted Stock Units (RSUs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Grants in period (in shares)     19,484,000    
Unrecognized share based compensation expense     $ 566,400,000    
Share based payment award vesting period     4 years    
Vested in period     $ 526,100,000 $ 453,200,000 $ 421,000,000
Unrecognized share based compensation expense, period for recognition (in years)     3 years    
P-RSUs          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Grants in period (in shares)     1,976,000    
Unrecognized share based compensation expense     $ 0    
Share based payment award vesting period     3 months    
P-RSUs | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Performance target (in percent)     0.00%    
P-RSUs | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Performance target (in percent)     100.00%    
2020 Equity Incentive Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares reserved for future issuance (in shares) 150,000,000 165,900,000      
Options granted (in shares)   162,000,000      
Outstanding stock maximum (in percent) 5.00%        
Ownership (in percent)     10.00%    
2020 Equity Incentive Plan | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Fair value of common stock (in percent)     110.00%    
2020 Equity Incentive Plan | Class A Common Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Additional shares authorized (in shares) 250,000,000        
Expiration period (in years)     10 years    
2020 Equity Incentive Plan | Restricted Stock Units (RSUs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Grants in period (in shares)   3,900,000      
2020 Extended Exercisability          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Expiration period (in years)     5 years    
Options vested and exercisable (in years)     4 years    
v3.24.0.1
Stock-Based Compensation - Summary of Stock Option Activity (Detail) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Options Outstanding    
Beginning balance (in shares) 326,913,000  
Options exercised (in shares) (46,079,000)  
Options canceled and forfeited (in shares) (2,364,000)  
Ending balance (in shares) 278,470,000 326,913,000
Options vested and exercisable, end of period (in shares) 160,877,000  
Weighted-Average Exercise Price Per Share    
Beginning balance (in dollars per share) $ 8.05  
Options exercised (in dollars per share) 4.74  
Options canceled and forfeited (in dollars per share) 5.39  
Ending balance (in dollars per share) 8.62 $ 8.05
Options vested and exercisable, end of period (in dollars per share) $ 6.66  
Weighted-Average Remaining Contractual Life (years) and Aggregate Intrinsic Value    
Options outstanding, Weighted-average remaining contractual life (in years) 7 years 7 months 20 days 8 years 3 months 29 days
Options vested and exercisable (in years) 6 years 11 months 4 days  
Options outstanding, aggregate intrinsic value $ 2,381,172 $ 272,603
Options vested and exercisable, end of period $ 1,691,404  
v3.24.0.1
Stock-Based Compensation - Summary of RSU And PRSU Activity (Detail)
 12 Months Ended
Dec. 31, 2023
$ / shares
shares
RSUs  
Units Outstanding  
Unvested and outstanding, beginning balance (in shares) | shares 126,426,000
Granted (in shares) | shares 19,484,000
Vested and converted to shares (in shares) | shares (54,974,000)
Canceled (in shares) | shares (8,674,000)
Unvested and outstanding, ending balance (in shares) | shares 82,262,000
Weighted Average Grant Date Fair Value per Share  
Unvested and outstanding, beginning balance (in dollars per share) | $ / shares $ 10.07
Granted (in dollars per share) | $ / shares 11.77
Vested and converted to shares (in dollars per share) | $ / shares 9.57
Cancelled (in dollars per share) | $ / shares 11.08
Unvested and outstanding, ending balance (in dollars per share) | $ / shares $ 10.71
P-RSUs  
Units Outstanding  
Unvested and outstanding, beginning balance (in shares) | shares 0
Granted (in shares) | shares 1,976,000
Vested and converted to shares (in shares) | shares 0
Canceled (in shares) | shares 0
Unvested and outstanding, ending balance (in shares) | shares 1,976,000
Weighted Average Grant Date Fair Value per Share  
Unvested and outstanding, beginning balance (in dollars per share) | $ / shares $ 0
Granted (in dollars per share) | $ / shares 15.39
Vested and converted to shares (in dollars per share) | $ / shares 0
Cancelled (in dollars per share) | $ / shares 0
Unvested and outstanding, ending balance (in dollars per share) | $ / shares $ 15.39
v3.24.0.1
Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense $ 475,903 $ 564,798 $ 778,215
Cost of revenue      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense 35,995 44,061 68,546
Sales and marketing      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense 160,645 196,301 242,910
Research and development      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense 98,064 93,871 150,298
General and administrative      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense $ 181,199 $ 230,565 $ 316,461
v3.24.0.1
Income Taxes - Summary of Loss Before Provision for (benefit from) Income Taxes (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Income (Loss) before Income Tax, Domestic and Foreign [Line Items]      
Income (loss) before provision for income taxes $ 237,091 $ (361,027) $ (488,494)
United States      
Schedule of Income (Loss) before Income Tax, Domestic and Foreign [Line Items]      
Income (loss) before provision for income taxes 174,637 (402,834) (514,200)
Foreign      
Schedule of Income (Loss) before Income Tax, Domestic and Foreign [Line Items]      
Income (loss) before provision for income taxes $ 62,454 $ 41,807 $ 25,706
v3.24.0.1
Income Taxes - Summary of Provision for (benefit from) Income Taxes (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Current:      
Federal $ 0 $ 0 $ 0
State 2,333 765 (88)
Foreign 22,189 9,476 (11,343)
Total current provision 24,522 10,241 (11,431)
Deferred:      
Federal 0 0 (111)
State 0 0 0
Foreign (4,806) (174) 43,427
Deferred income taxes (4,806) (174) 43,316
Total provision for income taxes $ 19,716 $ 10,067 $ 31,885
v3.24.0.1
Income Taxes - Summary of Reconciliation of Effective Income Tax Rate (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Effective Income Tax Rate Reconciliation, Amount [Abstract]      
Expected tax (benefit) at U.S. federal statutory rate $ 49,789 $ (75,592) $ (102,584)
State income taxes - net of federal benefit 2,309 766 (88)
Foreign tax rate differential 859 832 870
Research and development tax credits (45,667) (34,546) (94,591)
Stock-based compensation (79,128) 1,374 (817,839)
Non-deductible officers’ compensation 34,479 40,629 428,682
Change in valuation allowance 35,070 49,833 616,572
Base Erosion Anti-Abuse Tax and related elections 14,700 25,200 0
Taxes withheld at source 4,378 0 0
Non-deductible expenses 3,610 0 0
Other (683) 1,571 863
Total provision for income taxes $ 19,716 $ 10,067 $ 31,885
v3.24.0.1
Income Taxes - Additional Information (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Contingency [Line Items]        
Total provision for income taxes $ 19,716 $ 10,067 $ 31,885  
Valuation allowance 2,102,251 2,051,655    
Valuation allowance, increase (decrease) 50,600 74,100    
Capitalized research and experimental expenses 214,848 70,839    
Outside basis difference 0 (6,512)    
Unrecognized tax benefits 112,016 81,904 $ 65,070 $ 75,557
United States        
Income Tax Contingency [Line Items]        
Net operating loss carryforwards 324,000 113,100    
Non-US        
Income Tax Contingency [Line Items]        
Net operating loss carryforwards 464,700      
California Franchise Tax Board        
Income Tax Contingency [Line Items]        
Deferred tax assets, tax credit carryforwards, research 99,500 91,400    
Domestic Tax Authority        
Income Tax Contingency [Line Items]        
Net operating loss carryforwards 5,000,000 5,600,000    
Operating loss carryforwards, not subject to expiration 4,200,000      
Deferred tax assets, tax credit carryforwards, research 290,100 230,200    
State and Local Jurisdiction | California Franchise Tax Board        
Income Tax Contingency [Line Items]        
Net operating loss carryforwards $ 2,500,000 $ 2,800,000    
v3.24.0.1
Income Taxes - Summary of Significant Deferred Tax Assets and Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Components of Deferred Tax Assets and Liabilities [Abstract]    
Net operating loss carryforwards $ 1,317,684 $ 1,436,957
Capitalized research and experimental expenses 214,848 70,839
Reserves and accruals 99,105 76,905
Tax credit carryforwards 277,060 226,565
Stock-based compensation 139,419 203,735
Lease liabilities 53,902 58,056
Depreciation and amortization 14,413 29,665
Capitalized facilitative expenses 28,906 0
Gross deferred tax assets 2,145,337 2,102,722
Outside basis difference 0 (6,512)
Acquisition related intangibles (8,428) (10,225)
Right-of-use assets (42,721) (46,295)
Total net deferred tax assets before valuation allowance 2,094,188 2,039,690
Valuation allowance (2,102,251) (2,051,655)
Net deferred tax assets (liabilities) $ (8,063) $ (11,965)
v3.24.0.1
Income Taxes - Summary of Reconciliation of the Gross Unrecognized Tax Benefits (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Unrecognized tax benefit beginning of year $ 81,904 $ 65,070 $ 75,557
Increases in current year tax positions 14,346 5,733 19,638
Increases in prior year tax positions 15,766 11,497 967
Decreases in prior year tax positions 0 (36) (30,895)
Decreases in prior year tax positions due to settlements 0 (360) (197)
Decreases in prior year tax positions due to lapse of statute of limitations 0 0 0
Unrecognized tax benefit end of year $ 112,016 $ 81,904 $ 65,070
v3.24.0.1
Net Earnings (Loss) Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Numerator      
Net income (loss) attributable to common stockholders for diluted net earnings (loss) per share $ 209,825 $ (373,705) $ (520,379)
Denominator      
Weighted-average shares used in computing net earnings (loss) per share, basic (in shares) 2,147,446 2,063,793 1,923,617
Effect of dilutive shares 150,481 0 0
Weighted-average shares used in computing net earnings (loss) per share, diluted (in shares) 2,297,927 2,063,793 1,923,617
Net earnings (loss) per share      
Net earnings (loss) per share attributable to common stockholders, basic (in dollars per share) $ 0.10 $ (0.18) $ (0.27)
Net earnings (loss) per share attributable to common stockholders, diluted (in dollars per share) $ 0.09 $ (0.18) $ (0.27)
v3.24.0.1
Net Earnings (Loss) Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail) - shares
shares in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 175,245 466,381 516,768
Options and SARs issued and outstanding      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 162,000 326,913 349,977
RSUs and P-RSUs outstanding      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 13,245 126,426 153,749
Warrants to purchase common stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 0 13,042 13,042
v3.24.0.1
Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]      
Revenues $ 2,225,012 $ 1,905,871 $ 1,541,889
Operating Segments      
Segment Reporting Information [Line Items]      
Revenues 2,225,012 1,905,871 1,541,889
Total contribution $ 1,245,555 $ 1,035,173 $ 899,429
Contribution margin (in percent) 56.00% 54.00% 58.00%
Operating Segments | Government      
Segment Reporting Information [Line Items]      
Revenues $ 1,222,215 $ 1,071,776 $ 897,356
Total contribution $ 724,970 $ 620,677 $ 541,883
Contribution margin (in percent) 59.00% 58.00% 60.00%
Operating Segments | Commercial      
Segment Reporting Information [Line Items]      
Revenues $ 1,002,797 $ 834,095 $ 644,533
Total contribution $ 520,585 $ 414,496 $ 357,546
Contribution margin (in percent) 52.00% 50.00% 55.00%
v3.24.0.1
Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]      
Income (loss) from operations $ 119,966 $ (161,201) $ (411,046)
Total stock-based compensation expense 475,903 564,798 778,215
Reconciling items      
Segment Reporting Information [Line Items]      
Income (loss) from operations 119,966 (161,201) (411,046)
Research and development expenses 306,560 265,808 237,189
General and administrative expenses 343,126 365,768 295,071
Total stock-based compensation expense 475,903 564,798 778,215
Operating Segments      
Segment Reporting Information [Line Items]      
Total contribution $ 1,245,555 $ 1,035,173 $ 899,429
v3.24.0.1
Segment and Geographic Information - Summary of Revenue by Geography (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disaggregation of Revenue [Line Items]      
Revenues $ 2,225,012 $ 1,905,871 $ 1,541,889
Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Revenues $ 2,225,012 $ 1,905,871 $ 1,541,889
Geographic Concentration Risk | Revenue Benchmark      
Disaggregation of Revenue [Line Items]      
Concentration risk (in percent) 100.00% 100.00% 100.00%
Geographic Concentration Risk | Revenue Benchmark | Minimum      
Disaggregation of Revenue [Line Items]      
Concentration risk (in percent) 10.00% 10.00% 10.00%
United States | Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Revenues $ 1,378,247 $ 1,161,416 $ 879,156
United States | Geographic Concentration Risk | Revenue Benchmark      
Disaggregation of Revenue [Line Items]      
Concentration risk (in percent) 62.00% 61.00% 57.00%
United Kingdom | Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Revenues $ 235,257 $ 220,942 $ 173,362
United Kingdom | Geographic Concentration Risk | Revenue Benchmark      
Disaggregation of Revenue [Line Items]      
Concentration risk (in percent) 11.00% 12.00% 11.00%
Rest of world | Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Revenues $ 611,508 $ 523,513 $ 489,371
Rest of world | Geographic Concentration Risk | Revenue Benchmark      
Disaggregation of Revenue [Line Items]      
Concentration risk (in percent) 27.00% 27.00% 32.00%
v3.24.0.1
Segment and Geographic Information - Summary of Property and Equipment, Net by Geography (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Property and equipment, net $ 47,758 $ 69,170
Geographic Concentration Risk    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Property and equipment, net $ 47,758 $ 69,170
Geographic Concentration Risk | Property, Plant and Equipment    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Concentration risk (in percent) 100.00% 100.00%
United States | Geographic Concentration Risk    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Property and equipment, net $ 28,825 $ 46,599
United States | Geographic Concentration Risk | Property, Plant and Equipment    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Concentration risk (in percent) 60.00% 67.00%
Japan | Geographic Concentration Risk    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Property and equipment, net $ 11,440 $ 13,318
Japan | Geographic Concentration Risk | Property, Plant and Equipment    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Concentration risk (in percent) 24.00% 19.00%
United Kingdom | Geographic Concentration Risk    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Property and equipment, net $ 5,851 $ 6,746
United Kingdom | Geographic Concentration Risk | Property, Plant and Equipment    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Concentration risk (in percent) 12.00% 10.00%
Rest of world | Geographic Concentration Risk    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Property and equipment, net $ 1,642 $ 2,507
Rest of world | Geographic Concentration Risk | Property, Plant and Equipment    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Concentration risk (in percent) 4.00% 4.00%
v3.24.0.1
Business Combinations - Narrative (Details) - USD ($)
 12 Months Ended
Nov. 08, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]        
Gain from step acquisition   $ 0 $ 44,306,000 $ 0
Palantir Technologies Japan, K.K.        
Business Acquisition [Line Items]        
Fair value on acquisition date $ 149,000,000      
Equity interest immediately prior to the acquisition 74,500,000      
Noncontrolling interest 74,500,000      
Recognized identifiable assets acquired and liabilities assumed, cash 66,700,000      
Goodwill 36,100,000      
Recognized identifiable assets acquired and liabilities assumed, liabilities $ 21,000,000      
Goodwill recognized expected to be deductible for income tax purposes   $ 0    
Gain from step acquisition     $ 44,300,000  
Palantir Technologies Japan, K.K. | Minimum        
Business Acquisition [Line Items]        
Amortization period of finite-intangible assets (in years) 2 years      
Palantir Technologies Japan, K.K. | Maximum        
Business Acquisition [Line Items]        
Amortization period of finite-intangible assets (in years) 7 years      
Palantir Technologies Japan, K.K. | Customer Relationships, Reacquired Rights, Backlog        
Business Acquisition [Line Items]        
Recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles $ 34,700,000      
Palantir Technologies Japan, K.K. | Other        
Business Acquisition [Line Items]        
Recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles $ 32,500,000      
Palantir Technologies Japan, K.K.        
Business Acquisition [Line Items]        
Ownership percentage (in percent) 50.00%      
v3.24.0.1
Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 38,943 $ 40,436
Accumulated Amortization (13,041) (4,897)
Total $ 25,902 35,539
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Weighted average useful life 3 years 9 months 29 days  
Gross Carrying Amount $ 10,400 10,400
Accumulated Amortization (2,427) (347)
Total $ 7,973 10,053
Reacquired rights    
Finite-Lived Intangible Assets [Line Items]    
Weighted average useful life 5 years 9 months 29 days  
Gross Carrying Amount $ 17,618 17,619
Accumulated Amortization (2,936) (420)
Total $ 14,682 17,199
Backlog    
Finite-Lived Intangible Assets [Line Items]    
Weighted average useful life 9 months 29 days  
Gross Carrying Amount $ 6,700 6,700
Accumulated Amortization (3,908) (558)
Total $ 2,792 6,142
Other    
Finite-Lived Intangible Assets [Line Items]    
Weighted average useful life 3 months 7 days  
Gross Carrying Amount $ 4,225 5,717
Accumulated Amortization (3,770) (3,572)
Total $ 455 $ 2,145
v3.24.0.1
Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense of intangible assets $ 9.6 $ 0.0
v3.24.0.1
Intangible Assets - Expected Amortization Expense (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]    
2024 $ 7,844  
2025 4,597  
2026 4,597  
2027 4,250  
2028 2,517  
Thereafter 2,097  
Total $ 25,902 $ 35,539